[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 2995
1. Strassner C, Buhl R, Mehdorn HM: Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years? Neurol Res; 2009 Jun;31(5):478-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
  • OBJECTIVE: Meningiomas are benign intracranial tumors growing from the arachnoid cap cells.
  • METHODS: Between 1991 and 2002, 463 patients with an intracranial meningioma were operated in the Department of Neurosurgery, University of Kiel, Kiel, Germany.
  • We compared the outcome of these patients after operation and the different methods of radiation therapy and chemotherapy with the data from Buhl (1994), who analysed 661 patients with intracranial meningioma who were operated on in the Department of Neurosurgery, University of Essen, Essen, Germany, between 1968 and 1988, to find out whether better methods of diagnosis like magnetic resonance imaging scans, magnetic resonance spectroscopy, post-operative radiation therapy and chemotherapy have an influence on the recurrence and outcome after surgical treatment.
  • Both studies underlined the preponderance of female patients for intracranial meningiomas.
  • Complete removal of the tumor was possible in 86.7% in both studies.
  • The intracranial localization of the meningiomas was similar to the distribution of the histological subtypes and the rate of recurrence; only the malignant meningiomas showed a higher grade of recurrence in the last study.
  • The outcome of the patients after surgical removal was improving in the last years; the 30 day post-operative mortality after a primary operation on an intracranial meningioma decreased from 12.1 to 3%.
  • After removal of a recurrent meningioma, the mortality declined from 20 to 12.5%.
  • CONCLUSION: In the last 30 years, nothing important changed at the time of appearance of meningiomas, concerning the gender distribution and localisation as well as histological subtypes.
  • With better operating modalities and additional treatment with radiation and gamma knife, the mortality decreased significantly from 12 to 3% and the outcome of the patients is still improving, so that even elderly patients with intracranial meningioma can undergo surgical treatment with minor risks.
  • [MeSH-major] Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / therapy. Meningioma / diagnosis. Meningioma / therapy
  • [MeSH-minor] Combined Modality Therapy. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Radiosurgery. Time Factors. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19500450.001).
  • [ISSN] 0161-6412
  • [Journal-full-title] Neurological research
  • [ISO-abbreviation] Neurol. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


2. Roser F, Nakamura M, Jacobs C, Vorkapic P, Samii M: Sphenoid wing meningiomas with osseous involvement. Surg Neurol; 2005 Jul;64(1):37-43; discussion 43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sphenoid wing meningiomas with osseous involvement.
  • BACKGROUND: Sphenoid wing meningiomas (SWMs) with osseous involvement are neurosurgically challenging because of their position within the skull base and their high rates of recurrence.
  • Sufficient resection of these meningiomas requires extensive surgical exposure.
  • We report on 82 patients with meningiomas infiltrating the sphenoid wing, analyzing radiological appearance and its influence on surgical management.
  • Histological evaluation revealed World Health Organization grade I meningiomas in 94% of case patients, tumor infiltration of examined bone in all case patients, and proliferation rates of 2.2% Ki-67.
  • Recurrence rates in this subgroup of SWMs are higher (>30%) compared with meningiomas without osseous involvement (11.6%).
  • CONCLUSION: Osseous involvement in SWMs accounts for lower resection and higher recurrence rates than meningiomas in other locations.
  • [MeSH-major] Bone Neoplasms / radiography. Bone Neoplasms / surgery. Meningeal Neoplasms / radiography. Meningeal Neoplasms / surgery. Meningioma / radiography. Meningioma / surgery. Sphenoid Bone

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15993178.001).
  • [ISSN] 0090-3019
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. Oner AY, Tokgöz N, Tali ET, Uzun M, Isik S: Imaging meningiomas: is there a need for post-contrast FLAIR? Clin Radiol; 2005 Dec;60(12):1300-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Imaging meningiomas: is there a need for post-contrast FLAIR?
  • AIM: The aim of this study was to compare post-contrast fluid-attenuated inversion recovery (FLAIR) imaging with post-contrast T1-weighted images (T1WI) in depicting meningiomas.
  • MATERIALS AND METHODS: Twenty-nine patients with 46 meningiomas were included in this study.
  • The contrast enhancement degree, contrast enhancement pattern, lesion conspicuity, and the detection of the dural sign were compared between post-contrast FLAIR images and post-contrast T1WI.
  • RESULTS: The enhencement degree on FLAIR was equal or less than T1WI for all meningiomas.
  • Among 46 meningiomas 38 (83%) enhanced homogeneously and eight (17%) inhomogeneously on T1WI.
  • On contrast-enhanced FLAIR images, of the total 46 meningiomas 22 (48%) enhanced homogeneously, eight (17%) inhomogeneously, whereas 14 (30%) meningiomas showed a peripheral rim enhancement not observed on T1WI.
  • Two (5%) meningiomas showed no contrast enhancement on post-contrast FLAIR images.
  • Among the 14 meningiomas showing rim enhancement using FLAIR imaging, 12 (85%) were measured to be 2 cm or more in diameter.
  • A dural tail sign was found in 16 (35%) and 23 (50%) meningiomas on post-contrast T1WI and FLAIR images, respectively.
  • CONCLUSION: In contrast to other extra-axial diseases, post-contrast FLAIR sequence was not found to be a valuable adjunct to contrast-enhanced T1WI in the depiction of meningiomas.
  • [MeSH-major] Image Enhancement. Magnetic Resonance Imaging / methods. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16291312.001).
  • [ISSN] 0009-9260
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Publication-type] Comparative Study; Evaluation Studies; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


Advertisement
4. Yue Q, Shibata Y, Isobe T, Anno I, Kawamura H, Gong QY, Matsumura A: Absolute choline concentration measured by quantitative proton MR spectroscopy correlates with cell density in meningioma. Neuroradiology; 2009 Jan;51(1):61-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Absolute choline concentration measured by quantitative proton MR spectroscopy correlates with cell density in meningioma.
  • INTRODUCTION: This study was aimed to investigate the relationship between quantitative proton magnetic resonance spectroscopy (1H-MRS) and pathological changes in meningioma.
  • MATERIALS AND METHODS: Twenty-two meningioma cases underwent single voxel 1H-MRS (point-resolved spectroscopy sequence, repetition time/echo time = 2,000 ms/68, 136, 272 ms).
  • RESULTS: Average Cho concentration of all meningiomas before correction was 2.95 +/- 0.86 mmol/kg wet weight.
  • Average cell density of all meningiomas was 333 +/- 119 cells/HPF, and average proliferation index was 2.93 +/- 5.72%.
  • CONCLUSION: Absolute Cho concentration, especially Cho concentration corrected according to intra-voxel cystic/necrotic parts, reflects cell density of meningioma.
  • [MeSH-major] Brain Neoplasms / chemistry. Brain Neoplasms / pathology. Choline / analysis. Meningioma / chemistry. Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Brain / pathology. Brain Chemistry. Cell Count. Female. Humans. Immunohistochemistry. Linear Models. Magnetic Resonance Spectroscopy. Male. Middle Aged. Protons. Young Adult

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • Hazardous Substances Data Bank. CHOLINE CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 1987 Jan-Feb;8(1):65-70 [3028112.001]
  • [Cites] Neurosurgery. 2005 Apr;56(2 Suppl):291-8; discussion 291-8 [15794826.001]
  • [Cites] J Formos Med Assoc. 2004 Jun;103(6):448-58 [15278190.001]
  • [Cites] Neuroradiology. 1982;23 (4):207-9 [7121811.001]
  • [Cites] Cancer. 1993 Aug 1;72(3):639-48 [8334619.001]
  • [Cites] Eur J Radiol. 2006 Oct;60(1):48-55 [16844335.001]
  • [Cites] Clin Imaging. 2004 Jan-Feb;28(1):10-9 [14996441.001]
  • [Cites] J Neurooncol. 2000 Dec;50(3):215-26 [11263501.001]
  • [Cites] J Clin Neurosci. 2005 May;12(4):416-20 [15925772.001]
  • [Cites] Magn Reson Imaging. 1984;2(2):97-106 [6530924.001]
  • [Cites] Radiology. 2006 Aug;240(2):318-32 [16864664.001]
  • [Cites] Life Sci. 1996;58(22):1929-35 [8637421.001]
  • [Cites] Neurosurgery. 2005 Sep;57(3):538-50; discussion 538-50 [16145534.001]
  • [Cites] Neuroradiology. 2003 Mar;45(3):129-36 [12684713.001]
  • [Cites] J Neurosurg. 1999 Dec;91(6):928-34 [10584837.001]
  • [Cites] Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-95 [16331155.001]
  • [Cites] Magn Reson Imaging. 2002 May;20(4):343-9 [12165353.001]
  • [Cites] Magn Reson Imaging. 2003 Oct;21(8):923-8 [14599543.001]
  • [Cites] Neuroradiology. 2000 May;42(5):333-8 [10872152.001]
  • [Cites] Eur Radiol. 2002 Aug;12(8):2056-61 [12136324.001]
  • [Cites] J Neurooncol. 1996 Sep;29(3):197-205 [8858525.001]
  • [Cites] Radiology. 1986 Nov;161(2):369-75 [3763903.001]
  • [Cites] J Neurooncol. 2003 Jul;63(3):233-45 [12892229.001]
  • [Cites] Lancet. 2004 May 8;363(9420):1535-43 [15135603.001]
  • [Cites] Pol J Pathol. 2000;51(3):107-14 [11247393.001]
  • [Cites] Cancer Res. 1975 May;35(5):1164-7 [1120306.001]
  • [Cites] Magn Reson Imaging. 2003 Jul;21(6):663-72 [12915198.001]
  • [Cites] J Neurooncol. 2000 Apr;47(2):99-108 [10982150.001]
  • [Cites] Clin Neuropathol. 1988 Jan-Feb;7(1):16-21 [3370860.001]
  • [Cites] AJNR Am J Neuroradiol. 2000 Apr;21(4):659-65 [10782774.001]
  • (PMID = 19002445.001).
  • [ISSN] 1432-1920
  • [Journal-full-title] Neuroradiology
  • [ISO-abbreviation] Neuroradiology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Protons; N91BDP6H0X / Choline
  •  go-up   go-down


5. Fulkerson DH, Horner TG, Hattab EM: Histologically benign intraventricular meningioma with concurrent pulmonary metastasis: case report and review of the literature. Clin Neurol Neurosurg; 2008 Apr;110(4):416-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Histologically benign intraventricular meningioma with concurrent pulmonary metastasis: case report and review of the literature.
  • Only 1-2% of all meningiomas are intraventricular in location.
  • Metastasis from a histologically "benign" meningioma is a rare, but well-documented event.
  • However, there are only four reported cases in the literature of metastatic spread from a purely intraventricular meningioma.
  • The tumors in these reports had a frankly malignant histology or were associated with surgical manipulation and recurrence of the primary lesion.
  • In this report, the authors present a rare case of the concurrent presentation of a histologically benign intraventricular meningioma and a solitary lung lesion which proved to be metastatic meningioma.
  • [MeSH-major] Cerebral Ventricle Neoplasms / pathology. Lung Neoplasms / secondary. Magnetic Resonance Imaging. Meningeal Neoplasms / pathology. Meningioma / secondary. Tomography, X-Ray Computed
  • [MeSH-minor] Biomarkers, Tumor / analysis. Biopsy, Needle. Humans. Ki-67 Antigen / analysis. Lung / pathology. Male. Middle Aged. Mitotic Index. Mucin-1 / analysis. Receptors, Progesterone / analysis


6. Rogers L, Gilbert M, Vogelbaum MA: Intracranial meningiomas of atypical (WHO grade II) histology. J Neurooncol; 2010 Sep;99(3):393-405
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial meningiomas of atypical (WHO grade II) histology.
  • Atypical (WHO grade II) meningiomas occupy an intermediate risk group between benign (WHO grade I) and anaplastic (WHO grade III) meningiomas.
  • Although grade II meningiomas have traditionally been recognized in only about 5% of cases, after changes in diagnostic criteria with the current 2007 WHO standards, they now comprise approximately 20-35% of all meningiomas.
  • We will discuss the definition, diagnosis, and treatment of patients with atypical meningioma; review the current phase II cooperative trials; and draw attention to some questions timely for pre-clinical and clinical research.
  • [MeSH-major] Meningeal Neoplasms / pathology. Meningioma / pathology. Neoplasm Recurrence, Local / pathology
  • [MeSH-minor] Humans. Neoplasm Staging. Prognosis. World Health Organization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurgery. 2009 Jan;64(1):56-60; discussion 60 [19145156.001]
  • [Cites] Radiology. 1987 Aug;164(2):521-6 [3496626.001]
  • [Cites] J Neurooncol. 2000 Jun;48(2):151-60 [11083080.001]
  • [Cites] Clin Nucl Med. 2005 Nov;30(11):717-20 [16237292.001]
  • [Cites] J Neurooncol. 2007 Aug;84(1):41-7 [17361335.001]
  • [Cites] Neurol Res. 1999 Oct;21(7):640-4 [10555183.001]
  • [Cites] Acta Neurochir (Wien). 1995;135(3-4):171-8 [8748810.001]
  • [Cites] J Neurosurg. 2000 May;92(5):766-70 [10794289.001]
  • [Cites] J Neurosurg. 1997 May;86(5):793-800 [9126894.001]
  • [Cites] Brain Pathol. 2003 Jul;13(3):386-408 [12946028.001]
  • [Cites] Int J Cancer. 2003 May 10;104(6):728-34 [12640680.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 1;56(3):801-6 [12788188.001]
  • [Cites] Cancer. 1993 Aug 1;72(3):639-48 [8334619.001]
  • [Cites] Eur J Radiol. 2006 Oct;60(1):48-55 [16844335.001]
  • [Cites] J Neurosurg. 1999 Sep;91(3):384-90 [10470811.001]
  • [Cites] Neurol Res. 2007 Jan;29(1):43-6 [17427274.001]
  • [Cites] AJNR Am J Neuroradiol. 2008 Jun;29(6):1147-52 [18356472.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39 [13406590.001]
  • [Cites] Clin Radiol. 2007 Feb;62(2):109-19 [17207692.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):99-105 [11163502.001]
  • [Cites] Neuroradiology. 1990;32(6):467-73 [2287373.001]
  • [Cites] Neuropathol Appl Neurobiol. 2005 Apr;31(2):141-9 [15771707.001]
  • [Cites] Neurosurgery. 1993 Sep;33(3):394-9; discussion 399 [8413869.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):858-63 [17379447.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1996 Mar 1;34(4):817-22 [8598358.001]
  • [Cites] AJNR Am J Neuroradiol. 1996 Feb;17 (2):345-53 [8938309.001]
  • [Cites] Acta Neurochir (Wien). 1999;141(9):921-32 [10526073.001]
  • [Cites] Neurosurgery. 2009 Feb;64(2 Suppl):A7-13 [19165077.001]
  • [Cites] Clin Nucl Med. 2009 Jan;34(1):7-10 [19092373.001]
  • [Cites] J Clin Neurosci. 2003 Sep;10(5):589-93 [12948465.001]
  • [Cites] Neuroradiology. 2006 Aug;48(8):513-20 [16786348.001]
  • [Cites] J Neurosurg. 1999 Dec;91(6):928-34 [10584837.001]
  • [Cites] Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-95 [16331155.001]
  • [Cites] Cancer. 2002 Mar 1;94(5):1538-47 [11920512.001]
  • [Cites] Osaka City Med J. 1997 Dec;43(2):209-23 [9540343.001]
  • [Cites] AJNR Am J Neuroradiol. 2008 Oct;29(9):1630-5 [18583409.001]
  • [Cites] Chin Med J (Engl). 2008 Dec 5;121(23):2415-9 [19102960.001]
  • [Cites] Neurosurgery. 2003 Jul;53(1):62-70; discussion 70-1 [12823874.001]
  • [Cites] J Neurosurg. 2005 Jan;102 Suppl:283-6 [15662826.001]
  • [Cites] Clin Imaging. 2008 Jan-Feb;32(1):22-7 [18164390.001]
  • [Cites] Ann N Y Acad Sci. 1982;381:6-16 [6953802.001]
  • [Cites] Neurosurgery. 1993 Dec;33(6):955-63 [8134008.001]
  • [Cites] Eur J Nucl Med Mol Imaging. 2009 Oct;36(10 ):1574-82 [19377904.001]
  • [Cites] Strahlenther Onkol. 1998 Dec;174(12):624-8 [9879349.001]
  • [Cites] Surg Neurol. 2004 Feb;61(2):171-3 [14751635.001]
  • [Cites] Neurosurg Rev. 2006 Oct;29(4):293-6; discussion 296-7 [16953450.001]
  • [Cites] Am J Clin Oncol. 2005 Feb;28(1):70-4 [15685038.001]
  • [Cites] Cancer. 1999 May 1;85(9):2046-56 [10223247.001]
  • [Cites] Neurosurgery. 2010 Apr;66(4):661-8; discussion 668-9 [20305491.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8 [11846894.001]
  • [Cites] Neurosurgery. 2008 May;62(5 Suppl):A19-27; discussion A27-8 [18580776.001]
  • [Cites] Eur Radiol. 2003 Mar;13(3):582-91 [12594562.001]
  • [Cites] J Neurosurg. 1989 Nov;71(5 Pt 1):665-72 [2809720.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):57-61 [10656373.001]
  • [Cites] J Neurooncol. 1998 Aug;39(1):65-70 [9760071.001]
  • [Cites] Curr Opin Neurol. 2010 Dec;23(6):563-70 [20885321.001]
  • [Cites] Radiologia. 2009 Jul-Aug;51(4):411-9 [19552929.001]
  • [Cites] J Neurosurg. 1996 Jun;84(6):946-50 [8847588.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:108-11 [8738510.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):427-36 [9308947.001]
  • [Cites] J Nucl Med. 1997 Jan;38(1):26-30 [8998144.001]
  • [Cites] Surg Neurol. 2003 Oct;60(4):298-305; discussion 305 [14505844.001]
  • [Cites] AJNR Am J Neuroradiol. 2001 Jan;22(1):65-72 [11158890.001]
  • [Cites] Neurosurg Focus. 2008;24(5):E3 [18447742.001]
  • [Cites] Radiology. 2005 Jun;235(3):985-91 [15833979.001]
  • [Cites] Neurosurg Focus. 2007;23(4):E4 [17961041.001]
  • [Cites] J Neuroradiol. 1992;19(1):49-62 [1564530.001]
  • [Cites] Surg Neurol. 1986 Nov;26(5):461-9 [3764651.001]
  • [Cites] Mayo Clin Proc. 1998 Oct;73(10):936-42 [9787740.001]
  • [Cites] Lancet Neurol. 2006 Dec;5(12):1045-54 [17110285.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):399-406 [19203844.001]
  • (PMID = 20740303.001).
  • [ISSN] 1573-7373
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  •  go-up   go-down


7. Tashjian VS, Khanlou N, Vinters HV, Canalis RF, Becker DP: Hemangiopericytoma of the cerebellopontine angle: a case report and review of the literature. Surg Neurol; 2009 Sep;72(3):290-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Intracranial hemangiopericytoma represents a rare intracranial tumor that is typically difficult to distinguish from meningioma based on clinical presentation and radiographic findings.
  • These inherently aggressive neoplasms have been observed to occur in numerous intracranial compartments; however, isolated involvement of the CPA is essentially unreported.
  • The case is described; and a review of the literature pertaining to the diagnosis, optimal management, and follow-up for these lesions is provided.
  • The lesion proved to be an intracranial HPC on histologic sections.
  • CONCLUSION: Given the fundamentally different treatment approach for HPCs over other more common CPA tumors, it is imperative that the treating surgeon consider this rare diagnosis when evaluating patients with lesions localized to this area.
  • Specifically, gross total resection, followed by adjuvant SRT, provides patients with the highest probability for disease-free survival, based on current evidence in the neurosurgical literature.
  • [MeSH-major] Cerebellar Neoplasms / diagnosis. Cerebellar Neoplasms / therapy. Cerebellopontine Angle. Hemangiopericytoma / diagnosis. Hemangiopericytoma / therapy
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Magnetic Resonance Imaging. Meningioma / diagnosis. Meningioma / surgery. Neoplasm Recurrence, Local / prevention & control. Positron-Emission Tomography. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Hemangiopericytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18786704.001).
  • [ISSN] 1879-3339
  • [Journal-full-title] Surgical neurology
  • [ISO-abbreviation] Surg Neurol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 32
  •  go-up   go-down


8. Lehmann P, Vallée JN, Saliou G, Monet P, Bruniau A, Fichten A, De Marco G: Dynamic contrast-enhanced T2*-weighted MR imaging: a peritumoral brain oedema study. J Neuroradiol; 2009 May;36(2):88-92
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dynamic contrast-enhanced T2*-weighted MR imaging: a peritumoral brain oedema study.
  • BACKGROUND AND PURPOSE: Glioma and meningioma are the two most common types of primary brain tumor.
  • METHODS: In this prospective study, conducted from December 2003 to March 2005, out of 18 patients recruited, 12 were included (six with meningioma, six with glioblastoma).
  • Using rates of maximum signal drop (MSD), we drew regions of interest (ROI) starting near the lesion, and gradually moving outwards to areas of distant edema in axial and sagittal planes at 10, 20 and 30 mm from the tumor.
  • We also drew ROI on the contralateral brain white matter to obtain a normal baseline for comparison (relative MSD; rMSD).
  • RESULTS: In regions of peritumoral T2 hypersignals, we observed a decrease in rMSD with distance from glioblastoma due to reduced angiogenesis, and an increase in rMSD with distance from meningioma, probably due to a reduced mass effect.
  • CONCLUSION: In our study, dynamic susceptibility contrast MR perfusion imaging, using MSD as a parameter, revealed differences between meningioma and glioblastoma peritumoral tissue due to changes in angiogenesis.
  • [MeSH-major] Brain / pathology. Brain Edema / pathology. Brain Neoplasms / pathology. Glioma / pathology. Magnetic Resonance Imaging / methods. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Aged. Brain Mapping / methods. Diagnostic Imaging. Female. Humans. Image Processing, Computer-Assisted. Male. Middle Aged. Prospective Studies. Signal Processing, Computer-Assisted

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19054561.001).
  • [ISSN] 0150-9861
  • [Journal-full-title] Journal of neuroradiology. Journal de neuroradiologie
  • [ISO-abbreviation] J Neuroradiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] France
  •  go-up   go-down


9. Bajetto A, Barbieri F, Pattarozzi A, Dorcaratto A, Porcile C, Ravetti JL, Zona G, Spaziante R, Schettini G, Florio T: CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol; 2007 Jan;9(1):3-11
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro.
  • Chemokines participate in cellular processes associated with tumor proliferation, migration, and angiogenesis.
  • Here we studied the expression of this chemokine in human meningiomas and its possible role in cell proliferation.
  • Reverse transcriptase-PCR analysis for CXCR4 and SDF1 was performed on 55 human meningiomas (47 WHO grade I, 5 WHO II, and 3 WHO III).
  • Immunolabeling for CXCR4 and SDF1 was performed on paraffin-embedded sections of these tumors.
  • [(3)H]Thymidine uptake and Western blot analyses were performed on primary meningeal cell cultures of tumors to evaluate the proliferative activity of human SDF1alpha (hSDF1alpha) in vitro and the involvement of extracellular signal-regulated kinase 1/2 (ERK1/2) activation in this process.
  • CXCR4 mRNA was expressed by 78% of the tumor specimens and SDF1 mRNA by 53%.
  • CXCR4 and SDF1 were often detected in the same tumor tissues and colocalized with epithelial membrane antigen immunostaining.
  • In 9 of 12 primary cultures from meningiomas, hSDF1alpha induced significant cell proliferation that was strongly reduced by the mitogen-activated protein kinase kinase inhibitor PD98059, involving ERK1/2 activation in the proliferative signal of hSDF1alpha.
  • In conclusion, we found that human meningiomas express CXCR4 and SDF1 and that hSDF1alpha induces proliferation in primary meningioma cell cultures through the activation of ERK1/2.
  • [MeSH-major] Cell Proliferation. Chemokines, CXC / metabolism. Gene Expression Regulation, Neoplastic. Meningeal Neoplasms / metabolism. Meningioma / metabolism. Receptors, CXCR4 / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Blotting, Western. Carcinoma / genetics. Carcinoma / metabolism. Carcinoma / pathology. Chemokine CXCL12. Female. Humans. Immunoenzyme Techniques. In Vitro Techniques. Male. Middle Aged. Mitogen-Activated Protein Kinase 1 / metabolism. Mitogen-Activated Protein Kinase 3 / metabolism. RNA, Messenger / genetics. RNA, Messenger / metabolism. RNA, Neoplasm / genetics. RNA, Neoplasm / metabolism. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Stromal Cells / metabolism. Tumor Cells, Cultured

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8 [14595012.001]
  • [Cites] Neurochem Int. 2006 Oct;49(5):423-32 [16621164.001]
  • [Cites] Semin Cancer Biol. 2004 Jun;14(3):171-9 [15246052.001]
  • [Cites] Semin Cancer Biol. 2004 Jun;14(3):209-18 [15246057.001]
  • [Cites] Acta Neuropathol. 1996;91(5):504-10 [8740231.001]
  • [Cites] J Neurochem. 1999 Dec;73(6):2348-57 [10582593.001]
  • [Cites] Clin Cancer Res. 2000 Jan;6(1):102-11 [10656438.001]
  • [Cites] J Neurochem. 2001 Jun;77(5):1226-36 [11389173.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 May 14;99(10):7090-5 [11983855.001]
  • [Cites] Pharmacol Rev. 2002 Jun;54(2):227-9 [12037138.001]
  • [Cites] Nat Neurosci. 2002 Aug;5(8):719-20 [12080344.001]
  • [Cites] Development. 2002 Sep;129(18):4249-60 [12183377.001]
  • [Cites] J Neurochem. 2002 Sep;82(6):1311-29 [12354279.001]
  • [Cites] Neuroscience. 2002;115(1):295-305 [12401342.001]
  • [Cites] Cancer Res. 2003 Apr 15;63(8):1969-74 [12702590.001]
  • [Cites] Nature. 1996 Aug 15;382(6592):635-8 [8757135.001]
  • [Cites] Cancer. 1998 Jun 1;82(11):2262-9 [9610708.001]
  • [Cites] Nature. 1998 Jun 11;393(6685):595-9 [9634238.001]
  • [Cites] Neurosci Lett. 1998 Jun 19;249(2-3):163-6 [9682842.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9448-53 [9689100.001]
  • [Cites] Cancer. 1999 May 15;85(10):2249-54 [10326705.001]
  • [Cites] Ann N Y Acad Sci. 1999 Jun 22;876:201-9 [10415611.001]
  • [Cites] Curr Opin Neurol. 2004 Dec;17(6):687-92 [15542977.001]
  • [Cites] Exp Cell Res. 2005 Aug 15;308(2):241-53 [15921680.001]
  • [Cites] J Neurooncol. 2004 Jan;66(1-2):155-66 [15015781.001]
  • (PMID = 17108064.001).
  • [ISSN] 1522-8517
  • [Journal-full-title] Neuro-oncology
  • [ISO-abbreviation] Neuro-oncology
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CXCL12 protein, human; 0 / Chemokine CXCL12; 0 / Chemokines, CXC; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Receptors, CXCR4; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 1; EC 2.7.11.24 / Mitogen-Activated Protein Kinase 3
  • [Other-IDs] NLM/ PMC1828107
  •  go-up   go-down


10. McGovern SL, Aldape KD, Munsell MF, Mahajan A, DeMonte F, Woo SY: A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas. J Neurosurg; 2010 May;112(5):925-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
  • OBJECT: Despite a favorable outcome for most patients with WHO Grade I meningiomas, a subset of these patients will have recurrent or progressive disease that advances to a higher grade and requires increasingly aggressive therapy.
  • The goal of this study was to identify clinical characteristics associated with the recurrence of benign meningiomas and their acceleration to atypical and malignant histological types.
  • METHODS: Records of 216 patients with WHO Grade I, II, or III meningioma that were initially treated between 1965 and 2001 were retrospectively reviewed.
  • RESULTS: Patients with non-skull base cranial meningiomas (82 of 105 [78%]) were more likely to have undergone a gross-total resection than patients with skull base meningiomas (32 of 78 [41%]; p < 0.001).
  • Consequently, patients with Grade I non-skull base cranial meningiomas had better 5-year recurrence-free survival (69%) than patients with Grade I skull base meningiomas (56%) or Grade II or III tumors at any site (50%; p = 0.005).
  • Unexpectedly, patients with non-skull base tumors who experienced a recurrence (8 of 22 [36%]) were more likely than patients with skull base tumors (1 of 19 [5%]) to have a higher grade tumor at recurrence (p = 0.024).
  • Furthermore, the median MIB-1 labeling index of Grade I non-skull base cranial meningiomas (2.60%) was significantly higher than that of Grade I skull base tumors (1.35%; p = 0.016).
  • CONCLUSIONS: Cranial meningiomas that occur outside of the skull base are more likely to have a higher MIB-1 labeling index and recur with a higher grade than those within the skull base, suggesting that non-skull base cranial tumors may have a more aggressive biology than skull base tumors.
  • [MeSH-major] Brain Neoplasms / pathology. Meningioma / pathology. Neoplasm Recurrence, Local. Skull Base Neoplasms / pathology. World Health Organization
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Staging. Neurosurgical Procedures. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19799498.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Johnson LM, Hecht S, Arendse AU, Adams WH: What is your diagnosis? Cystic meningioma. J Am Vet Med Assoc; 2007 Sep 15;231(6):861-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] What is your diagnosis? Cystic meningioma.
  • [MeSH-major] Cysts / veterinary. Dog Diseases / diagnosis. Meningeal Neoplasms / veterinary. Meningioma / veterinary
  • [MeSH-minor] Animals. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy / veterinary. Craniotomy / veterinary. Diagnosis, Differential. Dogs. Drainage / veterinary. Female. Magnetic Resonance Imaging / methods. Magnetic Resonance Imaging / veterinary. Seizures / etiology. Seizures / veterinary. Tomography, X-Ray Computed / veterinary. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17867966.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Abboud H, Carpentier A, Martin-Duverneuil N, Kujas M, Hoang-Xuan K: MALT lymphoma presenting as a meningioma. J Neurooncol; 2005 Nov;75(2):221
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MALT lymphoma presenting as a meningioma.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Lymphoma, B-Cell, Marginal Zone / diagnosis. Lymphoma, B-Cell, Marginal Zone / pathology. Meningioma / diagnosis. Meningioma / pathology
  • [MeSH-minor] Antigens, CD20 / metabolism. Antimetabolites, Antineoplastic / therapeutic use. Antineoplastic Agents / therapeutic use. Biopsy. Diagnosis, Differential. Drug Therapy, Combination. Dura Mater / pathology. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Methotrexate / therapeutic use. Middle Aged. Neoplasm Staging. Procarbazine / therapeutic use. Treatment Outcome

  • Genetic Alliance. consumer health - Meningioma.
  • Hazardous Substances Data Bank. METHOTREXATE .
  • Hazardous Substances Data Bank. PROCARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1997 Jan;21(1):81-7 [8990144.001]
  • [Cites] Clin Neuropathol. 1998 Nov-Dec;17(6):311-7 [9832258.001]
  • (PMID = 16283446.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD20; 0 / Antimetabolites, Antineoplastic; 0 / Antineoplastic Agents; 0 / Biomarkers, Tumor; 35S93Y190K / Procarbazine; YL5FZ2Y5U1 / Methotrexate
  •  go-up   go-down


13. Utermark T, Kaempchen K, Antoniadis G, Hanemann CO: Reduced apoptosis rates in human schwannomas. Brain Pathol; 2005 Jan;15(1):17-22
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Schwannomas, tumors originating from Schwann cells, represent a frequent neurological tumor and can occur both in a genetic disorder called neurofibromatosis type 2 (NF2) and sporadically.
  • In both cases the genetic background is identical as all schwannomas are caused by biallelic mutations in the tumor suppressor gene NF2 coding for merlin.
  • Mutations in this gene have also been found to be responsible for 50% to 60% of spontaneous and 100% of the NF2 associated meningiomas.
  • Here, we report in vivo and in vitro evidence that the basal apoptosis rate of primary human schwannoma cells is reduced in comparison to that of normal Schwann cells, supporting the idea that in this benign tumor type, apoptosis has a role in tumorigenesis.

  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15779232.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Switzerland
  •  go-up   go-down


14. Romeike BF, Joellenbeck B, Skalej M, Scherlach C, Kirches E, Mawrin C: Intraventricular meningioma with fatal haemorrhage: clinical and autopsy findings. Clin Neurol Neurosurg; 2007 Dec;109(10):884-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intraventricular meningioma with fatal haemorrhage: clinical and autopsy findings.
  • Only a few cases of intraventricular meningioma have been reported and the association with intracranial haemorrhage is even rarer.
  • Here, we report a case of primary intraventricular meningioma with intraventricular haemorrhage in a 57-year-old woman.
  • A CT scan of the head initially suggested a malignant brain tumour as the lesion was quite inhomogeneous with hyper- and hypodense sections accompanied by fresh haemorrhage.
  • At autopsy, the tumour was histologically diagnosed as a fibroblastic meningioma WHO-Grade I.
  • [MeSH-major] Cerebral Hemorrhage / pathology. Cerebral Ventricle Neoplasms / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Brain / pathology. Brain Edema / pathology. Fatal Outcome. Female. Glasgow Coma Scale. Humans. Hydrocephalus / pathology. Lateral Ventricles / blood supply. Lateral Ventricles / pathology. Middle Aged. Neovascularization, Pathologic / pathology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17764829.001).
  • [ISSN] 0303-8467
  • [Journal-full-title] Clinical neurology and neurosurgery
  • [ISO-abbreviation] Clin Neurol Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


15. Daou MC, Smith TW, Litofsky NS, Hsieh CC, Ross AH: Doublecortin is preferentially expressed in invasive human brain tumors. Acta Neuropathol; 2005 Nov;110(5):472-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Doublecortin is preferentially expressed in invasive human brain tumors.
  • These facts led us to hypothesize that DCX is increased in invasive brain tumors.
  • DCX expression was assessed in 69 paraffin-embedded brain tumors of neuroepithelial origin.
  • In addition, mouse brain sections of the subventricular zone and dentate gyrus were used as positive controls for immunostaining, and specificity of antibody staining was demonstrated by peptide neutralization.
  • DCX was highly expressed in both high-grade invasive tumors (glioblastoma, n=11; anaplastic astrocytoma/oligoastrocytoma, n=7; and medulloblastoma/PNET, n=6) and low-grade invasive tumors (oligodendroglioma, n=3; and astrocytoma/oligoastrocytoma, n=5).
  • However, DCX was less intensely expressed in the circumscribed group of tumors (pilocytic astrocytoma, n=6; ependymoma/subependymoma, n=7; dysembryoplastic neuroepithelial tumor, n=4; ganglioglioma, n=2; meningioma, n=9; and schwannoma, n=9).
  • We conclude that DCX is preferentially expressed in invasive brain tumors.
  • In addition, DCX immunostaining was stronger at the margin of the tumor than at the center.
  • For a subset of these tumors, we also detected DCX mRNA and protein by Northern and Western blotting.
  • Collectively, the immunohistochemistry, Western blots and Northern blots conclusively demonstrate expression of DCX by human brain tumors.

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16195916.001).
  • [ISSN] 0001-6322
  • [Journal-full-title] Acta neuropathologica
  • [ISO-abbreviation] Acta Neuropathol.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / R01 NS021716; United States / NCI NIH HHS / CA / R21 CA107372; United States / NCI NIH HHS / CA / CA-10737; United States / NINDS NIH HHS / NS / NS-21716
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Microtubule-Associated Proteins; 0 / Neuropeptides; 0 / RNA, Messenger; 0 / doublecortin protein
  •  go-up   go-down


16. Bruneau M, George B: Classification system of foramen magnum meningiomas. J Craniovertebr Junction Spine; 2010 Jan;1(1):10-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Classification system of foramen magnum meningiomas.
  • BACKGROUND: Foramen magnum meningiomas (FMMs) are challenging tumors.
  • We report a classification system based on our experience of 107 tumors.
  • MATERIALS AND METHODS: The three main algorithm criteria included the compartment of development of the tumor, its dural insertion, and its relation to the vertebral artery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20890409.001).
  • [ISSN] 0976-9285
  • [Journal-full-title] Journal of craniovertebral junction & spine
  • [ISO-abbreviation] J Craniovertebr Junction Spine
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC2944858
  • [Keywords] NOTNLM ; Classification / foramen magnum / meningioma / surgical approach / tumor - vertebral artery
  •  go-up   go-down


17. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK: MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology; 2007 Oct;27(5):407-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas.
  • Histological analysis has limited value to predict biological behavior of meningiomas.
  • We investigated the utility of cell proliferative indicator in the evaluation of histologically benign meningiomas.
  • We selected 25 benign non-recurrent meningiomas, 15 benign recurrent meningiomas after complete surgical resection, 30 atypical meningiomas, and 15 anaplastic meningiomas out of 384 cases studied.
  • There was no dependable histological parameter to predict recurrence among benign-looking meningiomas.
  • The mean MIB-1 HLI values +/- SD were 3.47 +/- 2.0% for benign meningiomas, 5.08 +/- 4.0% for atypical meningiomas and 11.66 +/- 7.06% for anaplastic meningiomas.
  • In comparison, the mean MIB-1 HLI of benign non-recurrent meningiomas were 2.66 +/- 1.7% and with recurrence were 4.21 +/- 2.78% (P = 0.0339).
  • Using receiver operating characteristic, it was seen that neoplasm recurred with the MIB-1 HLI of > 2.6 having the sensitivity of 64.6% and specificity of 68% among benign (grade I) meningiomas.
  • MIB-1 positive tumor cells were maximally aggregated at the periphery of excised specimen.
  • MIB-1 HLI, integrated with standard histopathology can provide better information about the disease biological nature in benign meningiomas.
  • [MeSH-major] Biomarkers / analysis. Ki-67 Antigen / analysis. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Brain Neoplasms / pathology. Humans. Mitotic Index. Neoplasm Invasiveness. Probability. Recurrence. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18018472.001).
  • [ISSN] 0919-6544
  • [Journal-full-title] Neuropathology : official journal of the Japanese Society of Neuropathology
  • [ISO-abbreviation] Neuropathology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Ki-67 Antigen
  •  go-up   go-down


18. Galal A, Faisal A, Al-Werdany M, El Shehaby A, Lotfy T, Moharram H: Determinants of postoperative visual recovery in suprasellar meningiomas. Acta Neurochir (Wien); 2010 Jan;152(1):69-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Determinants of postoperative visual recovery in suprasellar meningiomas.
  • PURPOSE: Suprasellar meningiomas usually present with visual deterioration, including decreased visual acuity and/or visual field defects.
  • Suprasellar meningiomas have a close relationship with the optic apparatus, arteries of the anterior circulation, pituitary stalk and hypothalamus, which makes safe surgical resection a challenge especially with dissection around an already compromised optic apparatus.
  • In this report 21 patients operated on for a suprasellar meningioma over a 4-year period are reviewed.
  • METHODS: Over a 4-year period (2002-2006), patients surgically treated for suprasellar meningiomas were included in this retrospective study.
  • All tumors were located at the tuberculum sellae and diaphragma sellae dura.
  • The influence of patient age, sex, duration of symptoms, extent of visual impairment, tumor size , extent into optic canal, consistency, operative respectability were analyzed as potential prognostic factors for postoperative visual outcome.
  • Tumor removal was complete in 17 patients, and subtotal resection was performed in four patients.
  • A univariate analysis of clinical and surgical parameters thought to be related to visual outcome showed that the duration of symptoms, preoperative visual status, tumor size and adherence to the internal carotid arteries and/or anterior cerebral artery had a significant impact on visual outcome.
  • CONCLUSION: The extent and duration of visual symptoms, size of the tumor and vascular adherence were prognostic factors affecting visual recovery after microsurgical resection of suprasellar meningiomas.
  • [MeSH-major] Meningeal Neoplasms / physiopathology. Meningeal Neoplasms / surgery. Meningioma / physiopathology. Meningioma / surgery. Recovery of Function. Sella Turcica. Vision, Ocular

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19707716.001).
  • [ISSN] 0942-0940
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


19. Hardell L, Carlberg M, Söderqvist F, Hansson Mild K: Meta-analysis of long-term mobile phone use and the association with brain tumours. Int J Oncol; 2008 May;32(5):1097-103
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meta-analysis of long-term mobile phone use and the association with brain tumours.
  • We evaluated long-term use of mobile phones and the risk for brain tumours in case-control studies published so far on this issue.
  • Seven studies gave results for meningioma yielding overall OR = 0.8, 95% CI = 0.7-0.99.
  • [MeSH-major] Brain Neoplasms / etiology. Cell Phones. Glioma / etiology. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology. Neuroma, Acoustic / etiology

  • MedlinePlus Health Information. consumer health - Acoustic Neuroma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18425337.001).
  • [ISSN] 1019-6439
  • [Journal-full-title] International journal of oncology
  • [ISO-abbreviation] Int. J. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Meta-Analysis
  • [Publication-country] Greece
  •  go-up   go-down


20. Ozawa H, Kurata A, Suzuki S, Fujii K, Kan S: The platinum ball a new embolic material. Interv Neuroradiol; 2006 Jan 20;12(Suppl 1):148-53
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SUMMARY: Polyvinyl alcohol (PVA) particles have been widely used as an embolic material for endovascular treatment of vascular enriched tumors, especially for meningiomas.
  • We have therefore developed a new embolic material, platinum balls, which feature radioopacity, a relatively well-defined oval shape, multi-pitted and indented surfaces on electron microscopy and a lower tendency for self-adhesion Based on positive findings in experimental studies, embolization of meningiomas was conducted with platinum balls in 27 patients and the results compared with findings for a matched group previously treated with PVA particles.Total volume of blood transfused during surgery was comparable in the two cases, although a tendency for lower values was noted with the platinum balls, and outcome was equally positive.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] AJNR Am J Neuroradiol. 1986 Sep-Oct;7(5):963-72 [3096121.001]
  • [Cites] AJNR Am J Neuroradiol. 1989 Jul-Aug;10(4):777-86 [2505505.001]
  • [Cites] AJNR Am J Neuroradiol. 1995 Apr;16(4 Suppl):843-6 [7611054.001]
  • [Cites] J Neurosurg. 1993 Jan;78(1):60-9 [8416244.001]
  • [Cites] AJNR Am J Neuroradiol. 1999 Aug;20(7):1323-8 [10472993.001]
  • [Cites] Neurosurgery. 1997 Jan;40(1):112-20; discussion 120-1 [8971833.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 May-Jun;14(3):571-82 [8517342.001]
  • [Cites] Neurosurgery. 2001 May;48(5):984-95; discussion 995-7 [11334300.001]
  • [Cites] Interv Neuroradiol. 2004 Mar 30;10 Suppl 1:35-8 [20587269.001]
  • [Cites] Interv Neuroradiol. 2004 Mar 30;10 Suppl 1:135-42 [20587289.001]
  • [Cites] Radiology. 1979 Jun;131(3):669-79 [441373.001]
  • [Cites] Radiology. 1978 Mar;126(3):783-5 [628757.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1975 Nov;125(3):609-16 [1081841.001]
  • [Cites] J Neurosurg. 1992 Apr;76(4):607-14 [1545253.001]
  • [Cites] No Shinkei Geka. 1992 Apr;20(4):367-73 [1570057.001]
  • [Cites] J Neurosurg. 1992 Aug;77(2):217-22 [1625008.001]
  • [Cites] AJNR Am J Neuroradiol. 1990 Jan-Feb;11(1):163-8 [2105599.001]
  • [Cites] Radiol Clin North Am. 1971 Aug;9(2):203-18 [4938290.001]
  • (PMID = 20569621.001).
  • [ISSN] 1591-0199
  • [Journal-full-title] Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
  • [ISO-abbreviation] Interv Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3387943
  •  go-up   go-down


21. Ali K, Lu Y, Christensen C, May T, Hyett C, Griebel R, Fourney D, Meguro K, Resch L, Sharma RK: Fourier transform infrared spectromicroscopy and hierarchical cluster analysis of human meningiomas. Int J Mol Med; 2008 Mar;21(3):297-301
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fourier transform infrared spectromicroscopy and hierarchical cluster analysis of human meningiomas.
  • Limitations of conventional light microscopy in pathological diagnosis of brain tumors include subjective bias in interpretation and discordance of nomenclature.
  • A study using mid-infrared (IR) spectromicroscopy was undertaken to determine whether meningiomas, a group of brain tumors prone to recurrence, could be identified by the unique spectral 'fingerprints' of their chemical composition.
  • Paired, thin (5-microm) cryosections of snap-frozen human meningioma tumor samples removed at elective surgery were mounted on glass (hematoxylin and eosin-stained tissue section) and infrared (unstained tissue section) reflectance slides, respectively.
  • Concordance of the tumor-bearing areas identified in the stained section by a pathologist with the unstained IR tissue section was ensured using a novel digital grid and tumor-mapping system developed in our laboratory.
  • Compared with the normal control, tumor samples from four meningioma patients revealed a marked decrease in bands associated with unsaturated fatty acids, particularly in the bands at 3010, 2920, 2850, and 1735 cm(-1).
  • False color images of 5 and 6 clusters obtained by HCA identified dominant clusters corresponding to tumor tissue.
  • Corroboration of these findings in a larger number of meningiomas may allow for more precise identification of these and other types of brain tumors.
  • [MeSH-major] Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / pathology. Meningioma / diagnosis. Meningioma / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18288376.001).
  • [ISSN] 1107-3756
  • [Journal-full-title] International journal of molecular medicine
  • [ISO-abbreviation] Int. J. Mol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Greece
  •  go-up   go-down


22. Sundaram C, Uppin SG, Prasad BC, Sahu BP, Devi MU, Prasad VS, Purohit AK: Isolated Rosai Dorfman disease of the central nervous system presenting as dural-based and intraparenchymal lesions. Clin Neuropathol; 2005 May-Jun;24(3):112-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Isolated Rosai Dorfman disease of the central nervous system presenting as dural-based and intraparenchymal lesions.
  • OBJECTIVE: To report three patients with isolated Rosai Dorfman disease of the central nervous system.
  • CASE REPORTS: We report two patients with dural-based lesions diagnosed imageologically as meningiomas, and one patient with multiple intraparenchymal lesions diagnosed imageologically as lymphoma.
  • The diagnosis was established on surgically excised masses during histopathology.
  • CONCLUSIONS: Awareness of the entity and consideration in the differential diagnosis of dural-based/intraparenchymal lesions is necessary for diagnosis and prognosis.
  • [MeSH-major] Brain / pathology. Brain Diseases / pathology. Dura Mater / pathology. Histiocytosis, Sinus / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Histiocytes / immunology. Histiocytes / pathology. Humans. Immune Tolerance / immunology. Lymphoma / diagnosis. Macrophages / immunology. Macrophages / pathology. Magnetic Resonance Imaging. Male. Meningioma / diagnosis. Middle Aged. Nerve Fibers, Myelinated / pathology. Prognosis. S100 Proteins / metabolism. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Rosai-Dorfman disease.
  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15943162.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / S100 Proteins
  •  go-up   go-down


23. Maes L, Kalala JP, Cornelissen M, de Ridder L: Progression of astrocytomas and meningiomas: an evaluation in vitro. Cell Prolif; 2007 Feb;40(1):14-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Progression of astrocytomas and meningiomas: an evaluation in vitro.
  • By verifying the proliferation capacity, human telomerase reverse transcriptase (hTERT) expression and in vitro invasion, in a group of highly malignant glioblastomas, benign meningiomas and astrocytomas, at the initial stage of progression, we have analysed putative progression in vitro for proliferation and telomerase expression.
  • MATERIALS AND METHODS: The relative proliferation status (visualized with Ki-67 antibodies) and presence of hTERT protein was analysed in 27 intracranial tumours (6 astrocytomas, 8 glioblastomas and 13 meningiomas) by immunohistochemistry on paraffin-embedded biopsy tissue, as well as on primary tumour-derived cell cultures.
  • The group of benign meningiomas had a labelling index of 2.2 (SD = 2.7).
  • The group of benign meningiomas had a labelling index of 12.4 (SD = 19.2) for hTERT.
  • CONCLUSIONS: The elevated expression of hTERT and Ki-67 in vitro provides a potential prognostic tool for early detection of the progression of brain tumours.
  • [MeSH-major] Astrocytoma / pathology. Brain Neoplasms / pathology. Cell Proliferation. Ki-67 Antigen / biosynthesis. Meningeal Neoplasms / pathology. Meningioma / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / analysis. Child. Disease Progression. Female. Humans. Male. Middle Aged. Neoplasm Invasiveness. Prognosis. Telomerase / analysis. Tumor Cells, Cultured

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17227292.001).
  • [ISSN] 0960-7722
  • [Journal-full-title] Cell proliferation
  • [ISO-abbreviation] Cell Prolif.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Ki-67 Antigen; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


24. Amoli FA, Mehrabani PM, Tari AS: Aggressive orbital optic nerve meningioma with benign microscopic features: a case report. Orbit; 2007 Dec;26(4):271-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Aggressive orbital optic nerve meningioma with benign microscopic features: a case report.
  • Primary optic nerve meningiomas occur at lower ages than meningiomas arising from the coverings of the brain and spinal cord.
  • Here we report the case of a 20-year-old female with an aggressive orbital meningioma referred to the Ophthalmology Department of the Farabi Hospital in Tehran.
  • The patient had a history of orbital meningioma from 10 years ago and several surgical resections due to tumor recurrence during these 10 years.
  • Fine-needle aspiration cytology of the mass confirmed tumor recurrence.
  • The patient first received radiotherapy due to the inoperable mass, and the tumor was resected 1.5 month later.
  • Microscopic study showed meningotheliomatous meningioma with extensive involvement of the optic nerve and invasion of the optic disc, sclera and choroid.
  • The interesting aspect of this case was the aggressive behavior of the tumor with intraocular invasion, despite its benign histopathological features, which led to wide exenteration of the eye together with resection of the upper and lower lids.
  • [MeSH-major] Meningioma / pathology. Optic Nerve Neoplasms / pathology
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Humans. Magnetic Resonance Imaging. Neoplasm Invasiveness. Neoplasm Recurrence, Local

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18097966.001).
  • [ISSN] 0167-6830
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


25. Saeger W, Lüdecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S: Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol; 2007 Feb;156(2):203-16
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry.
  • In 1996, the German Registry of Pituitary Tumors was founded by the Pituitary Section of the German Society of Endocrinology as a reference center for collection and consultant pathohistological studies of pituitary tumors.
  • The data supplement former collections of the years 1970-1995 with 3480 surgically removed tumors or lesions of the pituitary region.
  • From 1996 on 3489 adenomas (84.6%), 5 pituitary carcinomas (0.12%), 133 craniopharyngiomas (3.2%), 39 meningiomas (0.94%), 25 metastases (0.6%), 22 chordomas (0.5%), 115 cystic non-neoplastic lesions (2.8%), and 46 inflammatory lesions (1.1%, 248 other lesions or normal tissue (6.0%)) were collected by us.

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17287410.001).
  • [ISSN] 0804-4643
  • [Journal-full-title] European journal of endocrinology
  • [ISO-abbreviation] Eur. J. Endocrinol.
  • [Language] ENG
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 98
  •  go-up   go-down


26. Loyant V, Jaffré A, Breton J, Baldi I, Vital A, Chapon F, Dutoit S, Lecluse Y, Loiseau H, Lebailly P, Gauduchon P: Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents. Mutagenesis; 2005 Sep;20(5):365-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Screening of TP53 mutations by DHPLC and sequencing in brain tumours from patients with an occupational exposure to pesticides or organic solvents.
  • The aetiology of brain tumours remains unclear.
  • The case-control study CEREPHY (221 cases, 442 controls) carried in the Departement de la Gironde in France revealed a significantly increased risk of brain tumours for subjects most exposed to pesticides.
  • These mutations are present in approximately 30% of astrocytic brain tumours.
  • In a pilot study, we explored the hypothesis that pesticide or solvent exposure could raise the frequency of TP53 mutations in brain tumour cells.
  • We investigated TP53 mutations in exons 2-11 by denaturing high performance liquid chromatography (DHPLC) and sequencing, and p53 accumulation by immunohistochemistry in brain tumour of the 30 patients from CEREPHY study with a history of occupational exposure to pesticides (n = 21) and/or organic solvents (n = 14) for whom tumoral tissue was available.
  • There were 12 gliomas, 6 meningiomas, 7 neurinomas, 2 central nervous system lymphomas and 3 tumours of other histological types.
  • These preliminary results, even if it was on a limited number of tumours, are not in favour of the role of pesticide or organic solvent exposure in the occurrence of TP53 mutations in brain tumours.
  • [MeSH-major] Brain Neoplasms / chemically induced. Mutagens / toxicity. Occupational Exposure. Pesticides / toxicity. Solvents / toxicity. Tumor Suppressor Protein p53 / genetics
  • [MeSH-minor] Case-Control Studies. Chromatography, High Pressure Liquid. DNA Mutational Analysis. DNA, Neoplasm / analysis. Exons / genetics. Female. Humans. Male. Mutation. Nucleic Acid Denaturation

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Occupational Health.
  • MedlinePlus Health Information. consumer health - Pesticides.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16105905.001).
  • [ISSN] 0267-8357
  • [Journal-full-title] Mutagenesis
  • [ISO-abbreviation] Mutagenesis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Mutagens; 0 / Pesticides; 0 / Solvents; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


27. Dusick JR, Esposito F, Kelly DF, Cohan P, DeSalles A, Becker DP, Martin NA: The extended direct endonasal transsphenoidal approach for nonadenomatous suprasellar tumors. J Neurosurg; 2005 May;102(5):832-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The extended direct endonasal transsphenoidal approach for nonadenomatous suprasellar tumors.
  • OBJECT: The extended transsphenoidal approach, which requires a bone and dural opening through the tuberculum sellae and posterior planum sphenoidale, is increasingly used for the treatment of nonadenomatous suprasellar tumors.
  • The authors present their experiences in using the direct endonasal approach in patients with nonadenomatous suprasellar tumors.
  • Bone and dural defects were repaired using abdominal fat, collagen sponge, titanium mesh, and, in most cases, lumbar drainage of cerebrospinal fluid (CSF).
  • Twenty-six procedures for tumor removal were performed in 24 patients (ages 9-79 years), including two repeated operations for residual tumor.
  • Gross-total removal could be accomplished in only 46% of patients, with near-gross-total removal or better in 74% of 23 patients (five of eight with craniopharyngiomas, six of seven with meningiomas, five of six with Rathke cleft cysts, and one of two with a dermoid or epidermoid cyst); a patient with a lymphoma only underwent biopsy.
  • Of 13 patients with tumor-related visual loss, 85% improved postoperatively.
  • The only permanent neurological deficit was anosmia in one patient; there were no intracranial vascular injuries.
  • CONCLUSIONS: The direct endonasal skull-base approach provides an effective minimally invasive means for resecting or debulking nonadenomatous suprasellar tumors that have traditionally been approached through a sublabial or transcranial route.
  • [MeSH-major] Brain Neoplasms / surgery. Minimally Invasive Surgical Procedures / methods. Neurosurgical Procedures / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Brain Diseases / surgery. Central Nervous System Cysts / surgery. Child. Craniopharyngioma / surgery. Epidermal Cyst / surgery. Humans. Meningeal Neoplasms / surgery. Meningioma / surgery. Middle Aged. Pituitary Neoplasms / surgery. Postoperative Complications. Sphenoid Bone. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2005 May;102(5):825-7; discussion 827-8 [15926704.001]
  • (PMID = 15926706.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Tanaka S, Pollock BE: Hearing preservation after stereotactic radiosurgery for bilateral cerebellopontine angle meningiomas. Minim Invasive Neurosurg; 2009 Oct;52(5-6):259-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hearing preservation after stereotactic radiosurgery for bilateral cerebellopontine angle meningiomas.
  • BACKGROUND: Preservation of cranial nerve function is critical in the management of patients with cerebellopontine angle (CPA) tumors.
  • CASE REPORT: A 51-year-old woman with tinnitus and dizziness was discovered to have bilateral CPA dural-based masses extending into the internal auditory canals (IAC).
  • The patient underwent two Leksell Gamma Knife (Elekta Instruments, Norcross, GA) radiosurgeries initially for the larger left-sided tumor, then one year later for the right.
  • The margin dose for each tumor was 14 Gy.
  • Six years after the first radiosurgery, the tumors have not progressed and she has retained normal hearing and facial function bilaterally.
  • CONCLUSION: Preservation of cranial nerve function is generally possible after stereotactic radiosurgery of CPA meningiomas.
  • [MeSH-major] Cerebellar Neoplasms / surgery. Cerebellopontine Angle / surgery. Hearing Loss, Bilateral / prevention & control. Meningioma / surgery. Radiosurgery / methods

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20077370.001).
  • [ISSN] 1439-2291
  • [Journal-full-title] Minimally invasive neurosurgery : MIN
  • [ISO-abbreviation] Minim Invasive Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


29. Teranishi K, Yamamoto T, Nakao Y, Osada H, Wada R, Mori K: Recurrent solitary fibrous tumor of the falx cerebri with intraventricular extension: case report. Neurol Med Chir (Tokyo); 2007 Jun;47(6):269-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent solitary fibrous tumor of the falx cerebri with intraventricular extension: case report.
  • A 61-year-old male presented with a recurrent solitary fibrous tumor (SFT) arising from the falx cerebri with intraventricular extension manifesting as nausea and vomiting.
  • Magnetic resonance imaging showed the heterogeneously enhanced tumor in the falx, which extended to the bilateral lateral ventricles and the third ventricle.
  • Total tumor removal was performed via the bifrontal interhemispheric approach.
  • Histological examination showed mostly spindle cells with rich intercellular fibers.
  • Reexamination of the two previous tumor specimens, previously identified as fibrous meningioma, found SFT.
  • The differential diagnosis of SFT in the central nervous system from fibrous meningioma and hemangiopericytoma requires immunohistochemistry and electron microscopy.
  • [MeSH-major] Dura Mater / pathology. Fibroma / pathology. Lateral Ventricles / pathology. Meningeal Neoplasms / pathology
  • [MeSH-minor] Antigens, CD34 / metabolism. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Intracranial Hypertension / etiology. Intracranial Hypertension / physiopathology. Magnetic Resonance Imaging. Male. Meningioma / diagnosis. Meningioma / physiopathology. Middle Aged. Nausea / etiology. Neoplasm Recurrence, Local. Neurosurgical Procedures. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17587780.001).
  • [ISSN] 0470-8105
  • [Journal-full-title] Neurologia medico-chirurgica
  • [ISO-abbreviation] Neurol. Med. Chir. (Tokyo)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antigens, CD34; 0 / Biomarkers, Tumor
  •  go-up   go-down


30. Nishio A, Ohata K, Tsuyuguchi N, Gotoh T, Ishiguro T, Kawakami T, Hara M: Pitfalls during the Embolization and Evaluation after the Embolization for the Skull Base Meningiomas. Interv Neuroradiol; 2006 Jan 20;12(Suppl 1):252-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pitfalls during the Embolization and Evaluation after the Embolization for the Skull Base Meningiomas.
  • SUMMARY: Pitfall during the embolization and evaluation after the embolization for skull base meningiomas supplied by meningeal arteries of internal carotid artery (ICA) are reported.
  • This study includes 15 cases of skull base meningiomas (two males and 13 females) that supplied by meningeal branches of internal carotid artery.
  • In ten patients among 15 patients the meningeal branches of ICA were dominant feeders.
  • In ten patients out of 15 patients, the embolization from the meningeal branches of ICA was possible.
  • During the embolization for skull base meningiomas, the existence of collateral pathways between the ICA system and external carotid artery system were identified.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chest. 2000 Apr;117(4):1162-72 [10767254.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 May-Jun;14(3):571-82 [8517342.001]
  • [Cites] Annu Rev Immunol. 1990;8:253-78 [2188664.001]
  • [Cites] AJNR Am J Neuroradiol. 1993 May-Jun;14(3):583-6 [8517343.001]
  • (PMID = 20569642.001).
  • [ISSN] 1591-0199
  • [Journal-full-title] Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
  • [ISO-abbreviation] Interv Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3387963
  •  go-up   go-down


31. Hussain S, Nanda A, Fowler M, Ampil FL, Burton GV: Primary intracranial leiomyosarcoma: report of a case and review of the literature. Sarcoma; 2006;2006:52140
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intracranial leiomyosarcoma: report of a case and review of the literature.
  • A stealth assisted craniotomy was performed with the provisional diagnosis of osteoblastic meningioma.
  • Further histopathologic analysis of the intracranial mass was consistent with leiomyosarcoma.
  • Staging evaluation, including CT and PET scans, demonstrated no other sites of disease.
  • Despite complete surgical resection and radiotherapy to the resection site, the disease recurred locally and systematically 5 months later.
  • Primary intracranial mesenchymal tumors are rare and few cases have been previously reported.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1958 Mar-Apr;11(2):264-77 [13511345.001]
  • [Cites] Neuroradiology. 1999 Jan;41(1):35-9 [9987766.001]
  • [Cites] Cancer. 2002 May 15;94(10):2706-11 [12173340.001]
  • [Cites] Histopathology. 1991 May;18(5):395-402 [1715839.001]
  • [Cites] Sem Hop. 1977 Oct 23;53(36):1927-40 [208159.001]
  • [Cites] J Neurosurg. 1989 Aug;71(2):279-82 [2746352.001]
  • [Cites] AJNR Am J Neuroradiol. 1987 Sep-Oct;8(5):911-2 [3118683.001]
  • [Cites] Neurosurgery. 1999 Jan;44(1):199-202 [9894982.001]
  • [Cites] J Clin Oncol. 2003 Jul 15;21(14):2719-25 [12860950.001]
  • [Cites] Acta Neurochir (Wien). 1996;138(12):1470-1 [9030357.001]
  • [Cites] Clin Neurol Neurosurg. 1997 Aug;99(3):210-2 [9350403.001]
  • (PMID = 17496995.001).
  • [ISSN] 1357-714X
  • [Journal-full-title] Sarcoma
  • [ISO-abbreviation] Sarcoma
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  • [Other-IDs] NLM/ PMC1779506
  •  go-up   go-down


32. Ketter R, Urbschat S, Henn W, Feiden W, Beerenwinkel N, Lengauer T, Steudel WI, Zang KD, Rahnenführer J: Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas. Int J Cancer; 2007 Oct 1;121(7):1473-80
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas.
  • Meningiomas are mostly benign tumors that originate from the coverings of brain and spinal cord.
  • Rare clinical progression of meningiomas is associated with a nonrandom pattern of secondary losses of other autosomes.
  • Deletion of the short arm of one chromosome 1 appears to be a decisive step for anaplastic growth in meningiomas.
  • We calculated an oncogenetic tree model that estimates the most likely cytogenetic pathways of 661 meningioma patients in terms of accumulation of somatic chromosome changes in tumor cells.
  • The genetic progression score (GPS) estimates the genetic status of a tumor as progression in the corresponding tumor cells along this model.
  • Large GPS values are highly correlated with early recurrence of meningiomas [p < 10(-4)].
  • We show that tumor location also has an impact on genetic progression.
  • Clinical relevance of the GPS is thus demonstrated with respect to origin, WHO grade and recurrence of the tumor.
  • As a quantitative measure the GPS allows a more precise assessment of the prognosis of meningiomas than categorical cytogenetic markers based on single chromosomal aberrations.
  • [MeSH-major] Chromosome Aberrations. Meningeal Neoplasms / pathology. Meningioma / pathology. Models, Genetic
  • [MeSH-minor] Adult. Aged. Chromosomes, Human, Pair 22. Clone Cells. Cytogenetics / methods. Disease Progression. Female. Follow-Up Studies. Gene Deletion. Humans. Karyotyping. Male. Middle Aged. Multivariate Analysis. Neoplasm Recurrence, Local / genetics. Retrospective Studies. Sex Factors. Time Factors. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17557299.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


33. Cavanaugh RP, Aiken SW, Schatzberg SJ: Intraventricular tension pneumocephalus and cervical subarachnoid pneumorrhachis in a bull mastiff dog after craniotomy. J Small Anim Pract; 2008 May;49(5):244-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • An eight-year-old bull mastiff dog underwent a craniotomy for surgical excision of an olfactory lobe meningioma.
  • Repair of a dural defect using synthetic dura substitute resulted in gradual resolution of neurological signs attributable to the tension pneumocephalus and subarachnoid space pneumorrhachis.
  • Regrowth of the meningioma was not observed.
  • Postoperative intraventricular tension pneumocephalus and air accumulation within subarachnoid space are uncommon but life-threatening complications of intracranial surgery.
  • Early diagnosis and treatment can result in a satisfactory outcome.
  • [MeSH-major] Craniotomy / veterinary. Dog Diseases / etiology. Meningeal Neoplasms / veterinary. Meningioma / veterinary. Pneumocephalus / veterinary. Postoperative Complications / veterinary
  • [MeSH-minor] Animals. Diagnosis, Differential. Dogs. Magnetic Resonance Imaging / veterinary. Male. Subarachnoid Space. Tomography, X-Ray Computed / veterinary. Treatment Outcome

  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18373545.001).
  • [ISSN] 0022-4510
  • [Journal-full-title] The Journal of small animal practice
  • [ISO-abbreviation] J Small Anim Pract
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. Magro G, Benkova K, Michal M: Meningioma-like tumor of the thyroid: a previously undescribed variant of follicular adenoma. Virchows Arch; 2005 Jun;446(6):677-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meningioma-like tumor of the thyroid: a previously undescribed variant of follicular adenoma.
  • [MeSH-major] Adenoma / pathology. Meningioma / pathology. Thyroid Neoplasms / pathology
  • [MeSH-minor] Aged. Diagnosis, Differential. Female. Humans. Immunohistochemistry

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Thyroid Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Adv Clin Path. 2000 Jan;4(1):35-9 [10936897.001]
  • [Cites] AMA Arch Pathol. 1954 Dec;58(6):554-63 [13217570.001]
  • [Cites] Endocr Pract. 2001 Sep-Oct;7(5):370-4 [11585373.001]
  • [Cites] Virchows Arch. 2005 Jan;446(1):91-2 [15517364.001]
  • [Cites] Am J Clin Pathol. 2002 Feb;117(2):199-204 [11863215.001]
  • (PMID = 15891903.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


35. Neeff M, Baysal E, Homer J, Gillespie J, Ramsden R: Intracranial/Extracranial meningioma arising in the hypoglossal canal: case report. Skull Base; 2007 Sep;17(5):325-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial/Extracranial meningioma arising in the hypoglossal canal: case report.
  • A case of a patient with a posterior fossa meningioma extending through the hypoglossal canal to the cervical region as described in this article has not been previously described in the literature.
  • A literature review including recent reports of extracranial meningiomas is presented.
  • Extracranial meningiomas are exceedingly rare and a high index of suspicion is necessary to make the diagnosis.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurol Res. 1999 Mar;21(2):161-70 [10100202.001]
  • [Cites] J Laryngol Otol. 1997 Feb;111(2):148-51 [9102441.001]
  • [Cites] HNO. 1999 Jun;47(6):573-6 [10427529.001]
  • [Cites] Neurosurgery. 1999 Aug;45(2):231-7; discussion 237-8 [10449066.001]
  • [Cites] J Laryngol Otol. 2000 Feb;114(2):149-50 [10748837.001]
  • [Cites] Mod Pathol. 2003 Mar;16(3):236-45 [12640104.001]
  • [Cites] Ear Nose Throat J. 2003 Apr;82(4):310-1 [12735162.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2003 Jul;260(6):322-4 [12883957.001]
  • [Cites] Am J Surg. 1960 Sep;100:486-9 [13716296.001]
  • [Cites] J Thorac Imaging. 2005 Feb;20(1):58-60 [15729126.001]
  • [Cites] No Shinkei Geka. 2005 Mar;33(3):271-5 [15773317.001]
  • [Cites] AJNR Am J Neuroradiol. 2005 May;26(5):1122-7 [15891170.001]
  • [Cites] Acta Radiol. 2005 Jul;46(4):415-8 [16134320.001]
  • [Cites] Neurosurgery. 1992 Jun;30(6):932-5 [1614599.001]
  • [Cites] J Laryngol Otol. 2006 Sep;120(9):786-8 [16762094.001]
  • [Cites] Acta Cytol. 1987 Jul-Aug;31(4):502-4 [3604545.001]
  • [Cites] Am J Surg. 1973 Oct;126(4):452-7 [4743832.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1971 Jun;80(3):464-73 [5578792.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1984 May-Jun;93(3 Pt 1):282-3 [6732115.001]
  • [Cites] Cancer. 1999 May 1;85(9):2046-56 [10223247.001]
  • (PMID = 18330431.001).
  • [ISSN] 1531-5010
  • [Journal-full-title] Skull base : official journal of North American Skull Base Society ... [et al.]
  • [ISO-abbreviation] Skull Base
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC2095119
  • [Keywords] NOTNLM ; Extracranial meningioma / carotid artery occlusion / meningioma classification / posterior fossa meningioma / thyroplasty
  •  go-up   go-down


36. Mitsuhara T, Ikawa F, Ohbayashi N, Imada Y, Abiko M, Inagawa T: [A case of petrotentorial meningioma presented as an acute subdural hemorrhage]. No Shinkei Geka; 2006 Aug;34(8):827-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of petrotentorial meningioma presented as an acute subdural hemorrhage].
  • The authors report a rare case of petrotentorial meningioma presenting as acute subdural hematoma.
  • CT and MRI demonstrated a petrotentorial tumor with a subdural hematoma in the posterior fossa.
  • The tumor was enhanced intensively on MRI and showed the dural tail sign.
  • After ventricular drainage, emergency intracranial decompression through hematoma evacuation and partial tumor resection was performed.
  • One month later, she improved clinically and the tumor resected totally in the second craniotomy.
  • Histological examination showed a meningothelial meningioma with high vascularity in part.
  • [MeSH-major] Hematoma, Subdural, Acute / etiology. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis

  • Genetic Alliance. consumer health - Meningioma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16910496.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


37. Liu M, Liu Y, Li X, Zhu S, Wu C: Cystic meninigioma. J Clin Neurosci; 2007 Sep;14(9):856-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To study the clinical characteristics of cystic meningiomas, we analyzed retrospectively 21 patients with cystic meningiomas and reviewed the literature with regard to clinical presentation, imaging features, preoperative diagnosis, surgical findings, and histopathological results.
  • The cysts were classified into intratumoral and peritumoral cysts based on their relationship to the tumor, and also according to the classification method described by Nauta.
  • Various pathophysiological mechanisms contribute to the formation of cystic meningiomas.
  • The diagnosis of cystic meningiomas based on CT scan can be problematic, and differentiation from glioma or metastasis may be difficult.
  • MRI scans show low signal intensity areas within the mass on T1-weighted images and high signal intensity areas on T2-weighted images, and the solid parts of tumors are contrast-enhanced after gadolinium administration.
  • MRI with gadolinium enhancement dramatically increases the diagnostic accuracy for cystic meningiomas and provides critical information for their surgical care.
  • Total surgical resection of cystic meningioma is ideal, but special attention should be paid to the cyst walls.
  • [MeSH-major] Cysts. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / therapy. Meningioma / diagnosis. Meningioma / therapy

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17596946.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


38. Cluroe AD: Metastasis to meningioma: clues and investigation. Pathology; 2006 Feb;38(1):76-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastasis to meningioma: clues and investigation.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / secondary. Meningioma / diagnosis. Meningioma / secondary
  • [MeSH-minor] Aged. Humans. Immunohistochemistry. Keratins / analysis. Male. Mucin-1 / analysis. Neoplasm Metastasis. Prostate-Specific Antigen / analysis. Prostatic Neoplasms / chemistry. Prostatic Neoplasms / diagnosis. Prostatic Neoplasms / pathology. Telencephalon / chemistry. Telencephalon / pathology

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16484016.001).
  • [ISSN] 0031-3025
  • [Journal-full-title] Pathology
  • [ISO-abbreviation] Pathology
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Mucin-1; 68238-35-7 / Keratins; EC 3.4.21.77 / Prostate-Specific Antigen
  •  go-up   go-down


39. Oh IH, Park BJ, Choi SK, Lim YJ: Transient neurologic deterioration after total removal of parasagittal meningioma including completely occluding superior sagittal sinus. J Korean Neurosurg Soc; 2009 Jul;46(1):71-3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Transient neurologic deterioration after total removal of parasagittal meningioma including completely occluding superior sagittal sinus.
  • In surgical planning of the parasagittal meningioma, invasion and occlusion of the superior sagittal sinus are important factors.
  • When tumor is located within anterior 1/3, or when angiographic finding shows total occlusion of superior sagittal sinus, it is regarded that the ligation of superior sagittal sinus is safe.
  • We report a case of parasagittal meningioma in 59-year-old male patient with complete occlusion of superior sagittal sinus which was confirmed by preoperative angiography, who developed temporary neurologic deterioration after superior sagittal sinus ligation and resection.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Zentralbl Neurochir. 2007 May;68(2):73-8 [17614087.001]
  • [Cites] J Neurosurg. 2006 Oct;105(4):514-25 [17044551.001]
  • [Cites] J Neurosurg. 2006 Oct;105(4):511-3; discussion 513 [17044550.001]
  • [Cites] Neurosurgery. 2004 Dec;55(6):1263-72; discussion 1272-4 [15574208.001]
  • [Cites] Neurosurgery. 1998 Sep;43(3):405-13; discussion 413-4 [9733295.001]
  • [Cites] Acta Neurochir (Wien). 1990;107(3-4):108-11 [2077846.001]
  • [Cites] Surg Neurol. 1986 May;25(5):436-40 [3961659.001]
  • [Cites] J Neurosurg. 1978 Jun;48(6):935-45 [660245.001]
  • [Cites] J Neurosurg. 2003 Oct;99(4):787-91 [14567620.001]
  • [Cites] Neurosurgery. 2001 Nov;49(5):1029-37; discussion 1037-8 [11846894.001]
  • [Cites] J Clin Neurosci. 2001 May;8 Suppl 1:8-11 [11386817.001]
  • [Cites] Adv Tech Stand Neurosurg. 2000;26:131-216 [10997200.001]
  • (PMID = 19707499.001).
  • [ISSN] 2005-3711
  • [Journal-full-title] Journal of Korean Neurosurgical Society
  • [ISO-abbreviation] J Korean Neurosurg Soc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2729830
  • [Keywords] NOTNLM ; Parasagittal meningioma / Superior sagittal sinus ligation / Transient neurologic deterioration
  •  go-up   go-down


40. Ferraz-Filho JR, Floriano VH, Felipe LF, Rocha-Filho JA: Clinical-radiological aspects of primary extracranial meningioma of the ethmoid sinus in a child. Arq Neuropsiquiatr; 2008 Jun;66(2A):274-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical-radiological aspects of primary extracranial meningioma of the ethmoid sinus in a child.
  • [MeSH-major] Ethmoid Sinus. Meningioma / diagnosis. Paranasal Sinus Neoplasms / diagnosis

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18545802.001).
  • [ISSN] 0004-282X
  • [Journal-full-title] Arquivos de neuro-psiquiatria
  • [ISO-abbreviation] Arq Neuropsiquiatr
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Brazil
  • [Number-of-references] 11
  •  go-up   go-down


41. Chopra R, Bhardwaj M, Premsagar IC: Fibrosarcoma of the meninges. Rare Tumors; 2010;2(1):e3
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Meningeal fibrosarcomas are rare tumors.
  • This is a case of a 13-year old boy with intracranial space occupying lesion.
  • The mass was completely removed and histological examination was characteristic of meningeal fibrosarcoma.
  • The pathological diagnosis is usually made on routine light microscopic examination; however, occasionally these may be difficult to distinguish from other malignant neoplasms such as gliomas, meningiomas and metastases.
  • The diagnosis of fibrosarcoma is based on the identification of a predominant herringbone architectural pattern, the overall uniformity of the spindle cell population, the prominent vimentin positivity, and the presence of pericellular reticulin fibre network.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21139948.001).
  • [ISSN] 2036-3613
  • [Journal-full-title] Rare tumors
  • [ISO-abbreviation] Rare Tumors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Italy
  • [Other-IDs] NLM/ PMC2994493
  • [Keywords] NOTNLM ; fibrosarcoma / herringbone pattern / meninges
  •  go-up   go-down


42. Montero Luis A, Hernanz de Lucas R, Hervás Morón A, Fernández Lizarbe E, Sancho García S, Vallejo Ocaña C, Polo Rubio A, Ramos Aguerri A: Radiation therapy for the treatment of benign vascular, skeletal and soft tissue diseases. Clin Transl Oncol; 2008 Jun;10(6):334-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Apart from the treatment of intracranial benign tumours, such as meningiomas and neurinomas, the prevention of cardiovascular restenosis or treatment of skeletal degenerative diseases are, without doubt, the main fields of action for radiation therapy in benign conditions.

  • MedlinePlus Health Information. consumer health - Vascular Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1989 Jun;67(6):706-15 [2544844.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1347-52 [10889389.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):669-72 [2506160.001]
  • [Cites] Urology. 2000 Dec 20;56(6):1030-4 [11113753.001]
  • [Cites] Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):8-19 [11272360.001]
  • [Cites] Radiother Oncol. 2005 Sep;76(3):270-7 [16157402.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1243-7 [11286830.001]
  • [Cites] Eur Urol. 2005 May;47(5):587-92 [15826748.001]
  • [Cites] Radiother Oncol. 1999 Dec;53(3):205-8 [10660199.001]
  • [Cites] Radiother Oncol. 2002 Apr;63(1):97-102 [12065109.001]
  • [Cites] Strahlenther Onkol. 2001 Feb;177(2):74-81 [11233838.001]
  • [Cites] Radiobiol Radiother (Berl). 1984;25(6):851-3 [6528027.001]
  • [Cites] Radiother Oncol. 2005 Jan;74(1):11-6 [15683662.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):63-73 [8083130.001]
  • [Cites] Cancer. 1993 Sep 1;72(5):1637-41 [8348495.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):496-513 [11872298.001]
  • [Cites] Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):36-41 [11272354.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1353-6 [10889390.001]
  • [Cites] Radiother Oncol. 2000 Mar;54(3):247-53 [10738083.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] Strahlenther Onkol. 2003 Nov;179(11):774-8 [14605748.001]
  • [Cites] Med Phys. 1999 Feb;26(2):119-52 [10076966.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):121-5 [11316554.001]
  • [Cites] Cardiovasc Radiat Med. 1999 Jan-Mar;1(1):42-7 [11272355.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2005 Mar 1;61(3):882-91 [15708271.001]
  • [Cites] Surg Gynecol Obstet. 1989 Aug;169(2):104-6 [2756458.001]
  • [Cites] J Bone Joint Surg Br. 2001 Apr;83(3):332-4 [11341414.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):571-6 [7852122.001]
  • [Cites] Cancer. 1987 Dec 15;60(12):2863-8 [2824015.001]
  • [Cites] J Bone Joint Surg Am. 1973 Dec;55(8):1629-32 [4217797.001]
  • [Cites] Cancer. 1984 Feb 15;53(4):869-73 [6420036.001]
  • [Cites] Semin Arthroplasty. 1992 Jul;3(3):156-66 [10147774.001]
  • [Cites] Cancer. 1992 Jun 15;69(12 ):2921-31 [1591685.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):476-83 [15380582.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10 ):1385-92 [11023100.001]
  • [Cites] Radiology. 1976 Feb;118(2):421-4 [814583.001]
  • [Cites] Acta Orthop Scand. 1998 Apr;69(2):116-8 [9602765.001]
  • [Cites] Arch Surg. 1989 Feb;124(2):191-6 [2916941.001]
  • [Cites] J Bone Joint Surg Am. 1996 Jun;78(6):870-81 [8666605.001]
  • [Cites] Circulation. 2004 Jan 27;109(3):340-4 [14732756.001]
  • [Cites] J Invest Dermatol. 1996 Apr;106(4):729-33 [8618012.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):756-65 [11697322.001]
  • [Cites] Radiother Oncol. 1998 Apr;47(1):17-28 [9632288.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1180-3 [12829157.001]
  • [Cites] Cancer. 2000 Apr 1;88(7):1517-23 [10738207.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):178-81 [12504051.001]
  • [Cites] Radiology. 1996 Jul;200(1):271-6 [8657925.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1994 Aug 30;30(1):55-62 [8083129.001]
  • [Cites] Radiother Oncol. 2003 Oct;69(1):73-7 [14597359.001]
  • [Cites] J Urol. 2000 Nov;164(5):1579-82 [11025708.001]
  • [Cites] Cancer. 1948 May;1(1):30-63 [18867439.001]
  • [Cites] N Engl J Med. 2001 Jan 25;344(4):250-6 [11172151.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):461-6 [10487572.001]
  • [Cites] Spine (Phila Pa 1976). 1998 Mar 1;23 (5):621-8 [9530795.001]
  • [Cites] Semin Radiat Oncol. 1999 Apr;9(2):203-14 [10092712.001]
  • [Cites] Br J Radiol. 2002 Feb;75(890):180-4 [11893644.001]
  • [Cites] J Am Podiatr Med Assoc. 1993 Jan;83(1):39-42 [8419629.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Aug 1;26(5):851-8 [8344854.001]
  • [Cites] J Clin Pathol. 1993 May;46(5):425-8 [8320323.001]
  • [Cites] Int J Radiat Biol. 2003 Dec;79(12 ):993-1001 [14713577.001]
  • [Cites] Radiother Oncol. 1999 Jun;51(3):197-203 [10435813.001]
  • [Cites] J Pediatr Surg. 1988 Feb;23(2):109-11 [3278084.001]
  • [Cites] Urology. 2003 Jan;61(1):145-51 [12559286.001]
  • [Cites] J Orthop Trauma. 1994;8(1):34-9 [8169692.001]
  • [Cites] Strahlenther Onkol. 2003 Dec;179(12):847-53 [14652674.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jul;60(7):762-70; discussion, 770-1 [12089689.001]
  • [Cites] Clin Orthop Relat Res. 1971 May;76:231-43 [4931060.001]
  • [Cites] Radiother Oncol. 2005 Jan;74(1):3-9 [15683661.001]
  • [Cites] Radiother Oncol. 1986 Sep;7(1):1-5 [3775074.001]
  • [Cites] Rontgenpraxis. 2001;53(5):208-20 [11341017.001]
  • [Cites] Acta Orthop Scand. 1977;48(4):400-4 [411321.001]
  • [Cites] J Orthop Trauma. 1996;10(4):258-63 [8723404.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1986 Mar;12(3):407-8 [3957739.001]
  • [Cites] Strahlenther Onkol. 2003 Mar;179(3):158-66 [12627258.001]
  • [Cites] Horm Res. 1997;48(3):95-102 [11546925.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):888-95 [15465207.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):923-31 [11072147.001]
  • [Cites] Strahlenther Onkol. 1993 Feb;169(2):77-82 [8451728.001]
  • [Cites] J Arthroplasty. 1988;3(3):229-34 [3141590.001]
  • [Cites] Circulation. 2000 Aug 29;102(9):951-8 [10961957.001]
  • [Cites] Strahlenther Onkol. 2003 Nov;179(11):767-73 [14605747.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1983 Aug;9(8):1167-71 [6409853.001]
  • [Cites] Am J Surg. 1986 Feb;151(2):230-7 [3946757.001]
  • [Cites] Radiat Environ Biophys. 1991;30(3):161-3 [1924697.001]
  • [Cites] Clin Oncol (R Coll Radiol). 2004 Jun;16(4):290-8 [15214654.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1996 Nov 1;36(4):891-7 [8960518.001]
  • [Cites] Surg Neurol. 1998 Dec;50(6):535-47 [9870814.001]
  • (PMID = 18558580.001).
  • [ISSN] 1699-048X
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Italy
  • [Number-of-references] 96
  •  go-up   go-down


43. Ewald C, Hofmann T, Kuhn SA, Deufel T, Beetz C, Kalff R: Methylation-specific multiplex ligation-dependent probe amplification in meningiomas. J Neurooncol; 2008 Dec;90(3):267-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Methylation-specific multiplex ligation-dependent probe amplification in meningiomas.
  • Genomic loss and promotor methylation contribute to inactivation of tumor suppressor genes (TSGs).
  • Here, we apply MS-MLPA to a series of 15 meningiomas of different WHO grades.
  • The number of aberrations identified per tumor increased with histopathologically determined grading.
  • The most frequent single event was deletion of the von Hippel-Lindau (VHL) gene in 12 of the 15 tumors.
  • Methylation was rare, being observed in only four tumors and in each case restricted to a single gene.
  • We conclude that a meningioma-specific MS-MLPA probe set would be a valuable tool for both research and diagnostic approaches in these tumors.
  • [MeSH-major] DNA Methylation / physiology. Meningioma / genetics. Nucleic Acid Amplification Techniques / methods. Tumor Suppressor Proteins / genetics
  • [MeSH-minor] Follow-Up Studies. Gene Deletion. Gene Dosage / physiology. Humans. Ligases. Magnetic Resonance Imaging. Von Hippel-Lindau Tumor Suppressor Protein / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Neurol Belg. 2002 Jun;102(2):53-62 [12161900.001]
  • [Cites] Clin Cancer Res. 2004 Sep 15;10 (18 Pt 2):6290S-5S [15448019.001]
  • [Cites] J Clin Oncol. 2000 Feb;18(3):636-45 [10653879.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2007 Nov;133(11):1131-8 [18025318.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):183-90 [11958372.001]
  • [Cites] Nucleic Acids Res. 2005 Aug 16;33(14):e128 [16106041.001]
  • [Cites] Neurosurgery. 2004 Nov;55(5):1163-73 [15509323.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Neurosurgery. 2007 May;60(5):787-98; discussion 787-98 [17460514.001]
  • [Cites] J Neurooncol. 1999 Jan;41(2):167-74 [10222437.001]
  • [Cites] J Neuropathol Exp Neurol. 2001 Jun;60(6):628-36 [11398839.001]
  • [Cites] Am J Pathol. 2001 Aug;159(2):661-9 [11485924.001]
  • [Cites] J Natl Cancer Inst. 1998 Oct 7;90(19):1473-9 [9776413.001]
  • [Cites] Nucleic Acids Res. 2002 Jun 15;30(12 ):e57 [12060695.001]
  • [Cites] Lab Invest. 2007 Oct;87(10 ):1055-65 [17700563.001]
  • [Cites] Acta Neuropathol. 2007 Aug;114(2):97-109 [17618441.001]
  • [Cites] Cancer Genet Cytogenet. 2007 Mar;173(2):170-2 [17321335.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2006 Jun;132(6):668-77 [16785414.001]
  • [Cites] Cancer Genet Cytogenet. 1999 Apr 15;110(2):103-10 [10214357.001]
  • [Cites] Diagn Mol Pathol. 2005 Mar;14(1):9-16 [15714058.001]
  • [Cites] J Mol Diagn. 2006 Sep;8(4):433-43 [16931583.001]
  • [Cites] Genes Chromosomes Cancer. 2002 Aug;34(4):349-53 [12112523.001]
  • [Cites] Clin Chem Lab Med. 2004;42(6):595-601 [15259374.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 [9405679.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Eur J Cancer. 2002 Aug;38(12):1580-4 [12142045.001]
  • [Cites] Brain Pathol. 2002 Apr;12(2):145-53 [11958368.001]
  • [Cites] Cancer. 2003 Feb 1;97(3 Suppl):825-33 [12548582.001]
  • [Cites] N Engl J Med. 2005 Mar 10;352(10 ):997-1003 [15758010.001]
  • [Cites] J Neurosurg. 2007 Aug;107(2):398-404 [17695396.001]
  • [Cites] Mod Pathol. 2007 Dec;20(12):1253-62 [17873900.001]
  • [Cites] J Pathol. 2007 Sep;213(1):46-55 [17668415.001]
  • [Cites] J Clin Oncol. 2004 Dec 15;22(24):4991-5004 [15611513.001]
  • (PMID = 18763019.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Tumor Suppressor Proteins; EC 2.3.2.27 / Von Hippel-Lindau Tumor Suppressor Protein; EC 6.- / Ligases
  •  go-up   go-down


44. Fons Martínez MR, España Gregori E, Aviñó Martínez JA, Hernández Pardines F: [An optic nerve tumor in von Hippel-Lindau disease, masquerading as a retinal hemangioma]. Arch Soc Esp Oftalmol; 2006 May;81(5):293-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [An optic nerve tumor in von Hippel-Lindau disease, masquerading as a retinal hemangioma].
  • [Transliterated title] Angioma retiniano como síndrome mascarada de tumor del nervio óptico en la enfermedad de von Hippel-Lindau.
  • CLINICAL CASE: A 35-year-old man with a family history of von Hippel-Lindau disease was diagnosed to have two retinal hemangiomas in the right eye and another in the left eye.
  • An MRI was then performed and showed bilateral tumoral lesions of the optic nerve compatible with a glioma, meningioma or hemangioblastoma.
  • DISCUSSION: The presence of the retinal hemangiomas delayed the diagnosis of an optic nerve tumor in this patient.
  • [MeSH-major] Hemangioma / complications. Hemangioma / diagnosis. Neoplasms, Multiple Primary / diagnosis. Optic Nerve Neoplasms / complications. Optic Nerve Neoplasms / diagnosis. Retinal Neoplasms / complications. Retinal Neoplasms / diagnosis. von Hippel-Lindau Disease / complications

  • Genetic Alliance. consumer health - Hemangioma.
  • MedlinePlus Health Information. consumer health - Birthmarks.
  • MedlinePlus Health Information. consumer health - Von Hippel-Lindau Disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16752322.001).
  • [ISSN] 0365-6691
  • [Journal-full-title] Archivos de la Sociedad Española de Oftalmología
  • [ISO-abbreviation] Arch Soc Esp Oftalmol
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


45. Aniba K, Ghannane H, Attar H, Belaabidia B, Ait Benali S: [Cystic meningioma. Case report and literature review]. Neurochirurgie; 2007 Nov;53(5):361-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Cystic meningioma. Case report and literature review].
  • BACKGROUND: Cystic meningioma is a rare variety of meningioma.
  • It represents 1,6 to 10% of intracranial meningiomas, the authors report a case of intracranial cystic meningioma with a review of literature.
  • CT scan brain showed a left parietal tumor with double solid and cystic components thought to be glioma or metastasis preoperatively.
  • The tumor was totally removed.
  • The histological study showed a cystic meningioma.
  • CONCLUSION: Cystic meningioma is an uncommon tumor that should be considered in the differential diagnosis of brain tumors with a cystic component.
  • [MeSH-major] Meningioma / surgery
  • [MeSH-minor] Brain / pathology. Diagnosis, Differential. Female. Headache / etiology. Humans. Magnetic Resonance Imaging. Middle Aged. Neurosurgical Procedures. Paresis / etiology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17707865.001).
  • [ISSN] 0028-3770
  • [Journal-full-title] Neuro-Chirurgie
  • [ISO-abbreviation] Neurochirurgie
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


46. Feng YB, Li YL, Zhang ZR: [A case of misdiagnosis of acute inferior myocardial infarction in patient with meningiomas and dextroversion(no abstract).]. Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Oct;36(10):947
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [A case of misdiagnosis of acute inferior myocardial infarction in patient with meningiomas and dextroversion(no abstract).].
  • [MeSH-minor] Electrocardiography. Humans. Meningeal Neoplasms. Meningioma. Myocardial Infarction / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19102899.001).
  • [ISSN] 0253-3758
  • [Journal-full-title] Zhonghua xin xue guan bing za zhi
  • [ISO-abbreviation] Zhonghua Xin Xue Guan Bing Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  •  go-up   go-down


47. Baheti AD, Mahore AS, Zade BP, Jalali R: Meningioma and cavernous angioma following childhood radiotherapy. J Cancer Res Ther; 2010 Jul-Sep;6(3):333-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Meningioma and cavernous angioma following childhood radiotherapy.
  • We report a rare case of development of both a meningioma and a cavernous angioma following prophylactic cranial irradiation as a part of treatment of ALL.
  • [MeSH-major] Hemangioma / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology. Neoplasms, Second Primary / etiology. Precursor Cell Lymphoblastic Leukemia-Lymphoma / radiotherapy. Radiotherapy / adverse effects


48. Rossitti S: Preoperative embolization of lower-falx meningiomas with ethylene vinyl alcohol copolymer: technical and anatomical aspects. Acta Radiol; 2007 Apr;48(3):321-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Preoperative embolization of lower-falx meningiomas with ethylene vinyl alcohol copolymer: technical and anatomical aspects.
  • PURPOSE: To report the feasibility of using ethylene vinyl alcohol copolymer (EVAC) for embolization of lower-falx meningiomas.
  • A terminal branch of the middle cerebral artery in the proximity of the tumor was catheterized as near as possible or into the pre-falcine arterial anastomotic network around the superior sagittal sinus, and embolization with EVAC was performed with a standard injection technique.
  • RESULTS: This technique resulted in filling of the tumor-supplying dural arteries including all collaterals from both sides, filling of the dural territory of the tumor circulation, and some obliteration of the tumor's pial supply.
  • On later operation, the tumors could be removed from the inside out with minimal brain retraction.
  • CONCLUSION: Effective preoperative embolization of lower-falx meningiomas using EVAC is feasible.
  • This technique has a sound anatomical basis, and it can be used with benefit even in falx meningiomas with predominantly pial vascular supply.
  • [MeSH-major] Embolization, Therapeutic / methods. Meningeal Neoplasms / therapy. Meningioma / therapy. Polyvinyls / therapeutic use

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17453504.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  • [Chemical-registry-number] 0 / Polyvinyls; 25067-34-9 / ethylene-vinyl alcohol copolymer
  •  go-up   go-down


49. Murata H, Takahashi M, Takagi T, Katagiri H, Ito I, Ishida T: A case of primary extracranial meningioma of the forearm with bone invasion. Skeletal Radiol; 2007 Jun;36(6):551-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of primary extracranial meningioma of the forearm with bone invasion.
  • We report here a rare case of primary extracranial meningioma in a 73-year-old woman with an asymptomatic mass located in the left distal-dorsal forearm.
  • The histopathology of the specimen from incision biopsy was typical of meningioma, showing bland spindle cell proliferation with a whorling pattern.
  • Immunohistochemically, the tumor cells were positive for epithelial membrane antigen and vimentin, and negative for S-100 expression.
  • [MeSH-major] Bone Neoplasms / diagnosis. Magnetic Resonance Imaging. Meningioma / diagnosis
  • [MeSH-minor] Aged. Contrast Media. Diagnosis, Differential. Female. Forearm. Gadolinium DTPA. Humans. Immunohistochemistry. Radius / pathology

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Jpn J Clin Oncol. 2000 Jul;30(7):313-7 [11007165.001]
  • [Cites] J Neurosurg. 1983 May;58(5):778-80 [6834129.001]
  • [Cites] Acta Neuropathol. 1989;77(4):445-8 [2711832.001]
  • [Cites] Skeletal Radiol. 2001 Nov;30(11):639-42 [11810156.001]
  • [Cites] Clin Neurol Neurosurg. 1993 Sep;95(3):245-7 [8242969.001]
  • (PMID = 17342548.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


50. Park H, Hwang SC, Kim BT, Shin WH: Hemifacial spasm caused by a huge tentorial meningioma. J Korean Neurosurg Soc; 2009 Sep;46(3):269-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hemifacial spasm caused by a huge tentorial meningioma.
  • A rare case of hemifacial spasm caused by an ipsilateral tentorial meningioma is described.
  • Magnetic resonance imaging showed a huge tumor in the right cerebellar hemisphere, distant to the cerebello-pontine cistern.
  • After removing the tumor, the hemifacial spasm resolved completely.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Skull Base Surg. 2000;10(1):43-5 [17171100.001]
  • [Cites] Neurol Med Chir (Tokyo). 2001 Feb;41(2):87-9 [11255633.001]
  • [Cites] Acta Neurochir (Wien). 2005 Jul;147(7):787-9; discussion 789 [15900403.001]
  • [Cites] Neurol Sci. 2005 Apr;26(1):46-9 [15877188.001]
  • [Cites] Clin Neurol Neurosurg. 1998 Jun;100(2):104-11 [9746297.001]
  • [Cites] Rev Neurol (Paris). 1999 Apr;155(4):309-11 [10367329.001]
  • [Cites] Br J Neurosurg. 1996 Dec;10(6):603-5 [9115659.001]
  • [Cites] J Neurosurg. 1995 May;82(5):895-7 [7714618.001]
  • [Cites] Neurosurgery. 1995 Feb;36(2):393-5 [7731520.001]
  • [Cites] J Neurooncol. 1993 Jan;15(1):37-43 [8455061.001]
  • [Cites] Surg Neurol. 1992 Sep;38(3):204-9 [1440205.001]
  • [Cites] Neurol Med Chir (Tokyo). 1991 Jul;31(7):410-3 [1720220.001]
  • [Cites] Neurology. 1987 Feb;37(2):339-42 [3808320.001]
  • [Cites] Neurology. 1984 Apr;34(4):418-26 [6322048.001]
  • [Cites] J Neurosurg. 1984 Apr;60(4):821-7 [6707751.001]
  • [Cites] J Neurosurg. 1977 Sep;47(3):321-8 [894338.001]
  • [Cites] Neurosurgery. 2002 Feb;50(2):276-85; discussion 285-6 [11844262.001]
  • [Cites] Surg Neurol. 2001 Jul;56(1):52-5 [11546578.001]
  • [Cites] Am J Otolaryngol. 2006 Jul-Aug;27(4):271-4 [16798407.001]
  • (PMID = 19844631.001).
  • [ISSN] 1598-7876
  • [Journal-full-title] Journal of Korean Neurosurgical Society
  • [ISO-abbreviation] J Korean Neurosurg Soc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2764029
  • [Keywords] NOTNLM ; Hemifacial spasm / Meningioma / Posterior fossa tumor
  •  go-up   go-down


51. Taomoto K, Ohnishi H, Nishihara M: [Surgery and outcome of meningiomas in elderly patients]. Nihon Rinsho; 2005 Sep;63 Suppl 9:607-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgery and outcome of meningiomas in elderly patients].
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery
  • [MeSH-minor] Aged. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Neurosurgical Procedures. Perioperative Care. Quality of Life. Radiosurgery. Radiotherapy, Adjuvant. Tomography, X-Ray Computed. Treatment Outcome

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16201589.001).
  • [ISSN] 0047-1852
  • [Journal-full-title] Nihon rinsho. Japanese journal of clinical medicine
  • [ISO-abbreviation] Nippon Rinsho
  • [Language] jpn
  • [Publication-type] Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 15
  •  go-up   go-down


52. Wallin JL, Tanna N, Misra S, Puri PK, Sadeghi N: Sinonasal carcinoma after irradiation for medulloblastoma in nevoid basal cell carcinoma syndrome. Am J Otolaryngol; 2007 Sep-Oct;28(5):360-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In addition, it has been associated with irradiation-induced neoplasms including, meningiomas, sarcomas, and gliomas.
  • RESULTS: To our knowledge, this is the first report of a sinonasal tumor after irradiation in a patient with NBCCS.
  • CONCLUSIONS: With this case, the authors examine the genotype of NBCCS patients and their propensity for radiation-induced tumors.
  • In addition, the management of neoplasms in these tumor-sensitive patients is reviewed.


53. Liu TC, Zhang T, Fukuhara H, Kuroda T, Todo T, Canron X, Bikfalvi A, Martuza RL, Kurtz A, Rabkin SD: Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors. Clin Cancer Res; 2006 Nov 15;12(22):6791-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dominant-negative fibroblast growth factor receptor expression enhances antitumoral potency of oncolytic herpes simplex virus in neural tumors.
  • Fibroblast growth factor (FGF) signaling is important for the growth and migration of endothelial and tumor cells.
  • EXPERIMENTAL DESIGN: A mouse Nf1:p53 malignant peripheral nerve sheath tumor (MPNST) cell line expressing dnFGFR was generated by transfection.
  • The effects of dnFGFR expression on cell growth and migration in vitro and tumor formation in vivo were determined.
  • RESULTS: MPNST 61E4 cells expressing dnFGFR grew less well than parental control cells. bG47Delta-dnFGFR showed enhanced killing of both tumor (human U87 glioma and F5 malignant meningioma cells and murine MPNST 61E4 and 37-3-18-4 cells) and proliferating endothelial cells (human umbilical vascular endothelial cell and Py-4-1) in vitro compared with the control vector bG47Delta-empty without inhibiting viral replication.
  • In vivo, bG47Delta-dnFGFR was more efficacious than its nonexpressing parent bG47Delta-empty at inhibiting tumor growth and angiogenesis in both human U87 glioma and mouse 37-3-18-4 MPNST tumors in nude mice.
  • CONCLUSIONS: By using multiple therapeutic mechanisms, including destruction of both tumor cells and tumor endothelial cells, an oncolytic HSV encoding dnFGFR enhances antitumor efficacy.
  • [MeSH-major] Brain Neoplasms / therapy. Glioblastoma / therapy. Oncolytic Virotherapy / methods. Receptors, Fibroblast Growth Factor / antagonists & inhibitors. Receptors, Fibroblast Growth Factor / genetics. Recombinant Proteins / therapeutic use. Simplexvirus
  • [MeSH-minor] Angiogenesis Inhibitors / therapeutic use. Animals. Antineoplastic Agents / therapeutic use. Cell Movement. Cell Proliferation. Chick Embryo. Endothelium, Vascular / metabolism. Genes, Dominant. Genetic Vectors / physiology. Genetic Vectors / therapeutic use. Humans. Mice. Mice, Nude. Signal Transduction. Treatment Outcome. Tumor Cells, Cultured. Virus Replication. Xenograft Model Antitumor Assays

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17121900.001).
  • [ISSN] 1078-0432
  • [Journal-full-title] Clinical cancer research : an official journal of the American Association for Cancer Research
  • [ISO-abbreviation] Clin. Cancer Res.
  • [Language] eng
  • [Grant] United States / NINDS NIH HHS / NS / R01 NS032677
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Angiogenesis Inhibitors; 0 / Antineoplastic Agents; 0 / Receptors, Fibroblast Growth Factor; 0 / Recombinant Proteins
  •  go-up   go-down


54. Waldron JS, Tihan T, Parsa AT: Solitary fibrous tumor arising from Cranial Nerve VI in the prepontine cistern: case report and review of a tumor subpopulation mimicking schwannoma. Neurosurgery; 2006 Oct;59(4):E939-40; discussion E940
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Solitary fibrous tumor arising from Cranial Nerve VI in the prepontine cistern: case report and review of a tumor subpopulation mimicking schwannoma.
  • OBJECTIVE: The authors present a report of a solitary fibrous tumor (SFT) arising from the intradural component of the VIth cranial nerve as it travels through the prepontine cistern.
  • SFTs of the central nervous system are extremely rare entities that clinically masquerade as dural-based lesions, such as meningiomas or hemangiopericytomas.
  • Because of their infrequency and clinical similarity to other central nervous system (CNS) lesions, diagnosis is largely dependent on pathological features.
  • The patient was then taken to the operating room by a combined neurosurgical and ear, nose, and throat team, where the patient underwent a retrolabyrinthine/subtemporal craniotomy for tumor resection.
  • During resection of the prepontine component, the tumor was identified as originating from the left Cranial Nerve VI as it traversed through the prepontine cistern.
  • Resection of the tumor component involving the cavernous sinus and Meckel's cave was deferred for follow-up treatment with intensity-modulated radiation therapy.
  • Pathological examination revealed tissue consistent with the diagnosis of SFT.
  • CONCLUSION: SFTs involving the CNS are rare entities that are almost always diagnosed after tissue is obtained because of their clinical and radiographic similarity to meningiomas.
  • Although the natural history of SFTs in the CNS is not completely understood, correct diagnosis is important, given the rate of recurrence found in the more common pleural-based SFT and examples of CNS SFTs with malignant features.
  • [MeSH-minor] Adult. Cerebral Angiography. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Radiotherapy, Adjuvant

  • Genetic Alliance. consumer health - Schwannoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17038929.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 26
  •  go-up   go-down


55. Shaia J, Kerr PB, Saini A, Roberti F, Kapil J, Jones R, Aragon-Ching JB: Mucosa-associated lymphoma tissue of the dura presenting as meningioma. South Med J; 2010 Sep;103(9):950-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mucosa-associated lymphoma tissue of the dura presenting as meningioma.
  • A subsequent magnetic resonance imaging (MRI) of the brain demonstrated a dural-based mass radiographically consistent with meningioma.
  • No evidence of systemic disease was found.
  • MALT lymphoma, while rare, must be considered in the differential diagnosis in patients presenting radiographically with meningioma.
  • [MeSH-major] Brain Neoplasms / diagnosis. Dura Mater / pathology. Lymphoma, B-Cell, Marginal Zone / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Dizziness / etiology. Female. Humans. Magnetic Resonance Imaging. Meningioma / diagnosis. Middle Aged. Nausea / etiology. Pain / etiology. Vomiting / etiology

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20689487.001).
  • [ISSN] 1541-8243
  • [Journal-full-title] Southern medical journal
  • [ISO-abbreviation] South. Med. J.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Henzel M, Gross MW, Hamm K, Surber G, Kleinert G, Failing T, Strassmann G, Engenhart-Cabillic R: Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study. Neurosurgery; 2006 Dec;59(6):1188-94; discussion 1194
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Significant tumor volume reduction of meningiomas after stereotactic radiotherapy: results of a prospective multicenter study.
  • OBJECTIVE: Stereotactic radiosurgery (SRS) is well established in the treatment of cranial base meningiomas.
  • Therefore, the aims of this prospective study were to quantitatively analyze tumor volume (TV) shrinkage and to calculate determining factors.
  • CONCLUSION: Meningiomas shrink significantly after SRT.
  • Eighteen to 24 months after irradiation, when symptoms are clinically stable, is the best time for the first magnetic resonance imaging scans evaluating tumor control and shrinkage.
  • [MeSH-major] Image Interpretation, Computer-Assisted / methods. Magnetic Resonance Imaging / methods. Meningeal Neoplasms / pathology. Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Radiosurgery / methods

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17277681.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


57. McIlwaine GG, Carrim ZI, Lueck CJ, Chrisp TM: A mechanical theory to account for bitemporal hemianopia from chiasmal compression. J Neuroophthalmol; 2005 Mar;25(1):40-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of chiasmal syndromes are caused by extrinsic compression from pituitary tumors, suprasellar meningiomas, craniopharyngiomas, and aneurysms.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neuroophthalmol. 2006 Sep;26(3):233; author reply 233-4 [16966949.001]
  • (PMID = 15756133.001).
  • [ISSN] 1070-8022
  • [Journal-full-title] Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • [ISO-abbreviation] J Neuroophthalmol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


58. Jurjević A, Bralić M, Bucuk M, Tuskan-Mohar L, Coklo M, Bosnar A: Trigeminal neuralgia secondary to meningioma of petroclival localization. Coll Antropol; 2009 Mar;33(1):323-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Trigeminal neuralgia secondary to meningioma of petroclival localization.
  • This article presents case of trigeminal neuralgia in a 55-year-old female patient caused by meningioma of petroclival localization.
  • [MeSH-major] Meningeal Neoplasms / complications. Meningioma / complications. Trigeminal Neuralgia / etiology


59. Buhl R, Nabavi A, Wolff S, Hugo HH, Alfke K, Jansen O, Mehdorn HM: MR spectroscopy in patients with intracranial meningiomas. Neurol Res; 2007 Jan;29(1):43-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] MR spectroscopy in patients with intracranial meningiomas.
  • With magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), we tried to get more pre-operative information in patients with suspicious meningioma concerning the histologic diagnosis especially regarding WHO Grades I and II meningiomas.
  • Apart from the known spectra and metabolites such as choline, creatine and N-acetyl-aspartate (NAA), recent publications have shown that lactate is often found in necrotic tumor tissue.
  • Within a 2 year period, 39 patients with an intracranial meningioma were studied with MRS.
  • In 62.5% of histologic atypical meningiomas (WHO Grade II), a lactate peak could be demonstrated in the pre-operative MRS.
  • Interestingly, also patients with multiple meningiomas show different spectra of their tumors.
  • [MeSH-major] Magnetic Resonance Spectroscopy / methods. Meningeal Neoplasms / diagnosis. Meninges / pathology. Meningioma / diagnosis
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Female. Humans. Lactic Acid / analysis. Lactic Acid / metabolism. Magnetic Resonance Imaging / methods. Male. Middle Aged. Neoplasm Invasiveness / diagnosis. Neoplasm Recurrence, Local / diagnosis. Predictive Value of Tests. Tomography, X-Ray Computed

  • Hazardous Substances Data Bank. LACTIC ACID .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17427274.001).
  • [ISSN] 0161-6412
  • [Journal-full-title] Neurological research
  • [ISO-abbreviation] Neurol. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 33X04XA5AT / Lactic Acid
  •  go-up   go-down


60. Kasuya H, Kubo O, Tanaka M, Amano K, Kato K, Hori T: Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev; 2006 Oct;29(4):293-6; discussion 296-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and radiological features related to the growth potential of meningioma.
  • Clinical and radiological features that help predict the growth potential of meningioma would be beneficial.
  • We analyzed the relationship of MIB-1 staining indices to characteristics of 342 consecutive patients with meningioma surgically removed between 1995 and 2004 by logistic regression analysis.
  • One hundred and forty-nine of the patients with meningioma were >or=60 in age; 89 male; 48 recurrent; 203 symptomatic; 157 at the skull base; 124 over 20 cm(3); 24 multiple; 136 with edema; 117 with calcification.
  • The MIB-1 staining index in 56 of 296 grade I meningiomas in WHO classification was >or= 3.0; in 27 of 28 grade II; and in 17 of 18 grade III, respectively.
  • These should be taken into consideration when managing meningiomas.
  • [MeSH-major] Meningioma / pathology
  • [MeSH-minor] Adult. Aged. Coloring Agents. Female. Humans. Ki-67 Antigen. Logistic Models. Male. Middle Aged. Neoplasm Staging. Neurosurgical Procedures. Odds Ratio. Risk Factors

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neurol Neurosurg Psychiatry. 2000 Jan;68(1):25-8 [10601396.001]
  • [Cites] J Neurosurg. 2000 May;92(5):766-70 [10794289.001]
  • [Cites] Acta Neurochir (Wien). 2000;142(5):507-11 [10898357.001]
  • [Cites] Cancer. 2002 Mar 1;94(5):1538-47 [11920512.001]
  • [Cites] Neurosurgery. 2003 Jul;53(1):62-70; discussion 70-1 [12823874.001]
  • [Cites] Neurosurg Rev. 2003 Jul;26(3):221-8 [12690530.001]
  • [Cites] Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44 [14740263.001]
  • [Cites] J Neurooncol. 2004 Mar-Apr;67(1-2):209-14 [15072469.001]
  • [Cites] Lancet. 2004 May 8;363(9420):1535-43 [15135603.001]
  • [Cites] Surg Neurol. 1985 Aug;24(2):165-72 [4012573.001]
  • [Cites] Surg Neurol. 1987 Apr;27(4):319-22 [3824137.001]
  • [Cites] J Pathol. 1992 Dec;168(4):357-63 [1484317.001]
  • [Cites] J Neurosurg. 1995 Aug;83(2):222-4 [7616265.001]
  • [Cites] Neurosurgery. 1995 Dec;37(6):1049-55 [8584144.001]
  • [Cites] Cancer. 1996 Jul 1;78(1):133-43 [8646709.001]
  • [Cites] Acta Neuropathol. 1996;91(5):504-10 [8740231.001]
  • [Cites] Acta Neurochir (Wien). 1998;140(1):26-31; discussion 31-2 [9522904.001]
  • [Cites] Cancer. 1998 Jun 1;82(11):2262-9 [9610708.001]
  • [Cites] Cancer. 1999 May 15;85(10):2249-54 [10326705.001]
  • [Cites] In Vivo. 2004 Jul-Aug;18(4):411-6 [15369177.001]
  • (PMID = 16953450.001).
  • [ISSN] 0344-5607
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Coloring Agents; 0 / Ki-67 Antigen
  • [Other-IDs] NLM/ PMC1564192
  •  go-up   go-down


61. Derlin T, Mester J, Klutmann S: Abnormal F-18 fluoride uptake in intracranial meningiomas on PET/CT. Clin Nucl Med; 2010 Oct;35(10):806-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Abnormal F-18 fluoride uptake in intracranial meningiomas on PET/CT.
  • The association between breast carcinoma and meningioma is a well-recognized phenomenon that may have important clinical implications, particularly in intracranial lesions.
  • We report 2 cases of intracranial meningioma in adult women with a history of breast cancer, who were imaged with positron emission tomography/computed tomography (PET/CT) for evaluation of possible bone metastases.
  • Whole-body F-18 fluoride PET demonstrated an intense intracranial focal radiotracer accumulation in both patients.
  • Simultaneous CT showed a corresponding calcified space-occupying lesion, consistent with meningioma.
  • Early and correct diagnosis of synchronous meningioma in F-18 fluoride bone scans might prevent relevant neurologic comorbidity.
  • [MeSH-major] Fluorides / metabolism. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / metabolism. Meningioma / diagnosis. Meningioma / metabolism. Positron-Emission Tomography. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20838293.001).
  • [ISSN] 1536-0229
  • [Journal-full-title] Clinical nuclear medicine
  • [ISO-abbreviation] Clin Nucl Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Fluorine Radioisotopes; Q80VPU408O / Fluorides
  •  go-up   go-down


62. Marucci G, Betts CM, Frank G, Foschini MP: Oncocytic meningioma: report of a case with progression after radiosurgery. Int J Surg Pathol; 2007 Jan;15(1):77-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncocytic meningioma: report of a case with progression after radiosurgery.
  • Oncocytic meningioma is an uncommon variant of meningioma, characterized histologically by cells rich in mitochondria.
  • This subtype of meningioma needs to be distinguished from other types of meningioma because of its more aggressive behavior.
  • A case of oncocytic meningioma showing rapid clinical progression with diffuse intracranial dissemination after radiosurgery is described.
  • Resistance to radiotherapy has been previously reported in oncocytic tumors of various body sites.
  • This new case is a further example of the greater aggressiveness of oncocytic meningioma, suggesting that radiation therapy might worsen the course of disease.
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / pathology. Meningioma / surgery. Radiosurgery
  • [MeSH-minor] Adenoma, Oxyphilic / pathology. Adenoma, Oxyphilic / surgery. Disease Progression. Female. Humans. Middle Aged. Neoplasm Recurrence, Local / pathology

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17172505.001).
  • [ISSN] 1066-8969
  • [Journal-full-title] International journal of surgical pathology
  • [ISO-abbreviation] Int. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


63. Jung DI, Park C, Kang BT, Kim JW, Kim HJ, Lim CY, Jeong SW, Park HM: Acquired cervical syringomyelia secondary to a brainstem meningioma in a maltese dog. J Vet Med Sci; 2006 Nov;68(11):1235-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acquired cervical syringomyelia secondary to a brainstem meningioma in a maltese dog.
  • A mass was noted in the brainstem on brain magnetic resonance images.
  • Based on diagnostic imaging findings, cervical syringomyelia secondary to a brainstem tumor was suspected.
  • The clinical signs were controlled well by lomustine and the dog survived for 8 months after the initial diagnosis.
  • The mass was diagnosed as a meningioma based on histopathological findings.
  • This report describes the clinical findings and imaging characteristics of an acquired syringomyelia resulting from a brainstem meningioma.

  • MedlinePlus Health Information. consumer health - Syringomyelia.
  • Hazardous Substances Data Bank. LOMUSTINE .
  • SciCrunch. OMIA - Online Mendelian Inheritance in Animals: Data: Gene Expression .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17146188.001).
  • [ISSN] 0916-7250
  • [Journal-full-title] The Journal of veterinary medical science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 7BRF0Z81KG / Lomustine
  •  go-up   go-down


64. Kaminsky J, Koerbel A, Mittelbronn M, Beschorner R, Ernemann U, Tatagiba M: Rosai-Dorfman disease involving the cranial base, paranasal sinuses and spinal cord. Clin Neuropathol; 2005 Jul-Aug;24(4):194-200
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Rosai-Dorfman disease involving the cranial base, paranasal sinuses and spinal cord.
  • Rosai-Dorfman disease is a lymphoproliferative disease that rarely involves the central nervous system.
  • Sinus histiocytosis with massive lymphadenopathy lesions may be dural-based and located in the skull base.
  • As these lesions may clinically and radiologically mimic meningiomas as well as other disorders, Rosai-Dorfman disease should be included in the differential diagnosis of extensive lesions involving the intracranial and spinal compartments along with meningiomatosis and inflammatory diseases.
  • The individual management of Rosai-Dorfman disease may be challenging due to diffuse involvement of neurovascular structures at the skull base.
  • [MeSH-major] Granuloma, Plasma Cell / diagnosis. Histiocytosis, Sinus / diagnosis. Paranasal Sinuses / pathology. Skull Base / pathology. Spinal Cord / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Magnetic Resonance Imaging. Male. Treatment Outcome

  • Genetic Alliance. consumer health - Rosai-Dorfman disease.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16033137.001).
  • [ISSN] 0722-5091
  • [Journal-full-title] Clinical neuropathology
  • [ISO-abbreviation] Clin. Neuropathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


65. Sughrue ME, Sanai N, Shangari G, Parsa AT, Berger MS, McDermott MW: Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas. J Neurosurg; 2010 Aug;113(2):202-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.
  • OBJECT: Despite an increased understanding of the biology of malignant meningioma tumor progression, there is a paucity of published clinical data on factors affecting outcomes following treatment for these lesions.
  • The authors present the largest case series to date dealing with these tumors, providing analysis of 63 patients.
  • METHODS: The authors identified all patients undergoing resection of WHO Grade III tumors at their institution over a 16-year period.
  • Twelve (19%) of 63 patients experienced significant neurological morbidity referable to the resection of their tumors.
  • CONCLUSIONS: Surgery is an effective treatment for WHO Grade III meningiomas at presentation and recurrence; however, aggressive attempts to achieve gross-total resection can be associated with significant neurological risk.
  • [MeSH-major] Meningeal Neoplasms. Meningioma. Neoplasm Recurrence, Local. Reoperation / mortality

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] J Neurosurg. 2010 Aug;113(2):199-200; discussion 200-1 [20225919.001]
  • [CommentIn] J Neurosurg. 2015 Jun;122(6):1514-5 [25859809.001]
  • (PMID = 20225922.001).
  • [ISSN] 1933-0693
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


66. Dickinson PJ, Sturges BK, Kass PH, LeCouteur RA: Characteristics of cisternal cerebrospinal fluid associated with intracranial meningiomas in dogs: 56 cases (1985-2004). J Am Vet Med Assoc; 2006 Feb 15;228(4):564-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Characteristics of cisternal cerebrospinal fluid associated with intracranial meningiomas in dogs: 56 cases (1985-2004).
  • OBJECTIVE: To determine CSF characteristics associated with intracranial meningiomas in dogs.
  • ANIMALS: 56 dogs with intracranial meningiomas.
  • PROCEDURES: Medical records of dogs with a histopathologic diagnosis of intracranial meningioma, in which CSF analysis had been performed, were reviewed.
  • Information concerning total nucleated cell counts (TNCCs) and differential nucleated cell counts, RBC counts, and total protein concentration in CSF; seizure history and glucocorticoid administration; and location of meningiomas was recorded.
  • There was a significant association between meningioma location (caudal portion of the cranial fossa or middle and rostral portion of the cranial fossae) and increased TNCCs (> or = 5 cells/microL).
  • Neutrophilic pleocytosis, especially with TNCCs > 50 cells/microL, was not typical in CSF samples from dogs with intracranial meningiomas.
  • Neutrophilic pleocytosis may not be detected in CSF samples from dogs with meningiomas located within the middle or rostral portion of the cranial fossae.
  • [MeSH-major] Cerebrospinal Fluid / cytology. Dog Diseases / cerebrospinal fluid. Meningioma / veterinary

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16478433.001).
  • [ISSN] 0003-1488
  • [Journal-full-title] Journal of the American Veterinary Medical Association
  • [ISO-abbreviation] J. Am. Vet. Med. Assoc.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cerebrospinal Fluid Proteins
  •  go-up   go-down


67. Ringel F, Cedzich C, Schramm J: Microsurgical technique and results of a series of 63 spheno-orbital meningiomas. Neurosurgery; 2007 Apr;60(4 Suppl 2):214-21; discussion 221-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Microsurgical technique and results of a series of 63 spheno-orbital meningiomas.
  • OBJECTIVE: For this study, spheno-orbital meningiomas (SOMs) are defined as intraosseus meningiomas at the base of the anterior and middle cranial fossa, involving the sphenoid wing and orbit associated with a carpet-like, soft tissue component.
  • Periorbital tumor infiltration led to intraorbital resection in 32 cases, and five cases presented a solid intraorbital tumor.
  • Seventy-six percent of patients had tumor residuals, of which 61% were stable and 39% were progressive.
  • Eleven tumor residuals were operated and four were treated by radiation.
  • Two-thirds of tumor rests remained stable during the follow-up period.
  • [MeSH-major] Brain Neoplasms / surgery. Meningioma / surgery. Microsurgery / methods. Neurosurgical Procedures / methods. Orbital Neoplasms / surgery. Skull Neoplasms / surgery. Sphenoid Bone / surgery
  • [MeSH-minor] Adult. Aged. Cranial Nerve Diseases / etiology. Exophthalmos / etiology. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm, Residual / radiotherapy. Neoplasm, Residual / surgery. Orbit / pathology. Orbit / surgery. Postoperative Complications / etiology. Reoperation. Retrospective Studies. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17415156.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


68. Konstantinidou AE, Givalos N, Gakiopoulou H, Korkolopoulou P, Kotsiakis X, Boviatsis E, Agrogiannis G, Mahera H, Patsouris E: Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas. Apoptosis; 2007 Apr;12(4):695-705
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Caspase-3 immunohistochemical expression is a marker of apoptosis, increased grade and early recurrence in intracranial meningiomas.
  • We investigated caspase-3 immunohistochemical expression in 58 primary intracranial meningiomas, using one monoclonal antibody detecting both precursor and cleaved caspase-3 (CPP32) and a second recognizing only the cleaved activated form (ASP175).
  • Caspase-3 expression was analyzed in relation to baseline apoptosis-as illustrated by the expression of anti-single stranded DNA (ss-DNA), the antiapoptotic protein bcl-2, proliferation indices (Ki-67, PCNA, topoisomerase IIa, mitosin C), hormonal status (estrogen, progesterone, androgen receptors), standard clinicopathological parameters and patients' disease-free survival.
  • Both CPP32 and ASP175 LIs were increased in nonbenign meningiomas (p<0.0001 and p=0.0035 respectively).
  • In univariate and multivariate survival analyses, caspase-3 predicted meningioma recurrence, independently affecting disease-free survival (p=0.011 and p=0.047 respectively for CPP32; p<0.0001 and p=0.012 respectively for ASP175).
  • [MeSH-major] Apoptosis / physiology. Biomarkers / metabolism. Caspase 3 / metabolism. Meningeal Neoplasms. Meningioma. Neoplasm Recurrence, Local

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17143787.001).
  • [ISSN] 1360-8185
  • [Journal-full-title] Apoptosis : an international journal on programmed cell death
  • [ISO-abbreviation] Apoptosis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers; 0 / Enzyme Precursors; 0 / Receptors, Steroid; EC 3.4.22.- / Caspase 3
  •  go-up   go-down


69. Monleón D, Morales JM, Gonzalez-Darder J, Talamantes F, Cortés O, Gil-Benso R, López-Ginés C, Cerdá-Nicolás M, Celda B: Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling. J Proteome Res; 2008 Jul;7(7):2882-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling.
  • Meningiomas are neoplasms that arise from the leptomeningeal covering of the brain and spinal cord, accounting for 15%-20% of CNS tumors.
  • The WHO classifies meningiomas into three histological grades: benign, atypical, and anaplasic in accordance with the clinical prognosis.
  • Atypical and anaplasic meningiomas tend to recur.
  • Sometimes, meningiomas with histological diagnosis of benign meningioma show clinical characteristics of atypical meningioma.
  • In this context, high-resolution magic-angle spinning (HR-MAS) spectroscopy of intact tissue from brain tumor biopsies has shown great potential as a support diagnostic tool.
  • In this work, we show differences between benign and atypical meningiomas in HR-MAS molecular profiles of meningioma biopsies.
  • Metabolic differences between meningioma grades include changes in the levels of glutathione.
  • Glutamine and glutamate, which are related to glutathione metabolism and have been associated with tumor recurrence, are also increased in atypical meningiomas.
  • Other metabolites associated with tumor malignancy that show statistically significant differences between benign and atypical meningiomas include phosphocholine and phosphoethanolamine.
  • Overall, this work suggests that the additional information obtained by NMR metabolomics applied to biopsies of human meningiomas may be useful for assessing tumor grade and determining optimum treatment strategies.
  • [MeSH-major] Meningeal Neoplasms / metabolism. Meningioma / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Female. Gene Expression Profiling. Humans. Magnetic Resonance Spectroscopy. Male. Middle Aged. Principal Component Analysis

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18507434.001).
  • [ISSN] 1535-3893
  • [Journal-full-title] Journal of proteome research
  • [ISO-abbreviation] J. Proteome Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


70. Roser F, Ebner FH, Ritz R, Samii M, Tatagiba MS, Nakamura M: Management of skull based meningiomas in the elderly patient. J Clin Neurosci; 2007 Mar;14(3):224-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management of skull based meningiomas in the elderly patient.
  • BACKGROUND: The demographic evolution of Western society together with availability of modern imaging techniques leads to an increasing diagnosis of meningioma patients over 70 years of age.
  • CONCLUSIONS: Age alone is not a criterion to deny a priori skull base surgery, since well selected geriatric patients may benefit from a meningioma operation that may enhance future quality of life.
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Age Distribution. Aged. Aged, 80 and over. Humans. Middle Aged. Morbidity. Neoplasm Recurrence, Local / mortality. Neurofibromatosis 2 / mortality. Neurofibromatosis 2 / surgery. Patient Selection. Postoperative Complications / mortality. Quality of Life. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17258130.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


71. James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V: NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol; 2009 Aug;29(15):4250-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth.
  • Inactivating mutations of the neurofibromatosis 2 (NF2) gene, NF2, result predominantly in benign neurological tumors, schwannomas and meningiomas, in humans; however, mutations in murine Nf2 lead to a broad spectrum of cancerous tumors.
  • The tumor-suppressive function of the NF2 protein, merlin, a membrane-cytoskeleton linker, remains unclear.
  • Here, we identify the mammalian target of rapamycin complex 1 (mTORC1) as a novel mediator of merlin's tumor suppressor activity.
  • Merlin-deficient human meningioma cells and merlin knockdown arachnoidal cells, the nonneoplastic cell counterparts of meningiomas, exhibit rapamycin-sensitive constitutive mTORC1 activation and increased growth.
  • NF2 patient tumors and Nf2-deficient mouse embryonic fibroblasts demonstrate elevated mTORC1 signaling.
  • In conclusion, the deregulation of mTORC1 activation underlies the aberrant growth and proliferation of NF2-associated tumors and may restrain the growth of these lesions through negative feedback mechanisms, suggesting that rapamycin in combination with phosphoinositide 3-kinase inhibitors may be therapeutic for NF2.

  • Genetic Alliance. consumer health - Meningioma.
  • Genetic Alliance. consumer health - Schwannoma.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. SIROLIMUS .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oncogene. 2004 Nov 18;23(54):8815-25 [15467741.001]
  • [Cites] J Virol Methods. 2004 Dec 15;122(2):131-9 [15542136.001]
  • [Cites] J Neurooncol. 2004 Nov;70(2):183-202 [15674477.001]
  • [Cites] Cell. 2005 Apr 22;121(2):179-93 [15851026.001]
  • [Cites] Genes Dev. 2005 Oct 1;19(19):2265-77 [16204178.001]
  • [Cites] J Cell Biol. 2005 Oct 24;171(2):361-71 [16247032.001]
  • [Cites] Neurosurgery. 2005 Dec;57(6):1088-95; discussion 1088-95 [16331155.001]
  • [Cites] Nat Cell Biol. 2006 Jan;8(1):27-36 [16341207.001]
  • [Cites] Cell. 2006 Feb 10;124(3):471-84 [16469695.001]
  • [Cites] Ann Neurol. 2006 Mar;59(3):490-8 [16453317.001]
  • [Cites] Mol Cell. 2006 Apr 21;22(2):159-68 [16603397.001]
  • [Cites] J Cell Biol. 2006 Apr 24;173(2):279-89 [16636147.001]
  • [Cites] Nat Rev Cancer. 2006 Sep;6(9):729-34 [16915295.001]
  • [Cites] Mol Cell. 2006 Oct 20;24(2):185-97 [17052453.001]
  • [Cites] Nat Cell Biol. 2007 Mar;9(3):316-23 [17277771.001]
  • [Cites] Mol Cell. 2007 Mar 23;25(6):903-15 [17386266.001]
  • [Cites] Cancer Cell. 2007 Jul;12(1):9-22 [17613433.001]
  • [Cites] Cell Res. 2007 Aug;17(8):666-81 [17680028.001]
  • [Cites] Genes Dev. 2007 Nov 1;21(21):2747-61 [17974916.001]
  • [Cites] N Engl J Med. 2008 Jan 10;358(2):140-51 [18184959.001]
  • [Cites] Neurobiol Dis. 2008 Feb;29(2):278-92 [17962031.001]
  • [Cites] Oncogene. 2008 Feb 14;27(8):1106-13 [17724476.001]
  • [Cites] Biochem J. 2008 Jun 1;412(2):179-90 [18466115.001]
  • [Cites] Mol Cell Biol. 2008 Jun;28(12):4104-15 [18411301.001]
  • [Cites] Cancer Res. 2004 Feb 1;64(3):812-6 [14871804.001]
  • [Cites] J Biol Chem. 2002 Nov 15;277(46):44180-6 [12226091.001]
  • [Cites] Ann Hum Genet. 2003 Jan;67(Pt 1):87-96 [12556239.001]
  • [Cites] Genes Dev. 2003 May 1;17(9):1090-100 [12695331.001]
  • [Cites] Nat Cell Biol. 2000 May;2(5):281-7 [10806479.001]
  • [Cites] J Neurosurg. 2001 Feb;94(2):293-300 [11213968.001]
  • [Cites] Genes Dev. 2001 Apr 15;15(8):968-80 [11316791.001]
  • [Cites] Annu Rev Biochem. 2001;70:535-602 [11395417.001]
  • [Cites] J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 [11895036.001]
  • [Cites] Nat Rev Mol Cell Biol. 2002 Aug;3(8):586-99 [12154370.001]
  • [Cites] J Clin Invest. 2003 Oct;112(8):1223-33 [14561707.001]
  • [Cites] Oncogene. 2004 Jan 15;23(2):580-7 [14724586.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94 [15342917.001]
  • [Cites] Cell. 1993 Mar 12;72(5):791-800 [8453669.001]
  • [Cites] Nature. 1993 Jun 10;363(6429):515-21 [8379998.001]
  • [Cites] Nat Genet. 1994 Feb;6(2):180-4 [8162072.001]
  • [Cites] Curr Opin Genet Dev. 1996 Feb;6(1):87-92 [8791482.001]
  • [Cites] EMBO J. 1996 Oct 1;15(19):5256-67 [8895571.001]
  • [Cites] JAMA. 1997 Jul 2;278(1):51-7 [9207339.001]
  • [Cites] Cancer Res. 1997 Sep 15;57(18):4141-7 [9307305.001]
  • [Cites] Oncogene. 1997 Nov 13;15(20):2505-9 [9395247.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14723-8 [9843956.001]
  • [Cites] Nat Cell Biol. 2004 Nov;6(11):1122-8 [15467718.001]
  • [Cites] J Cell Biol. 2004 Nov 8;167(3):399-403 [15533996.001]
  • [Cites] J Cell Biol. 2004 Dec 20;167(6):1171-82 [15611338.001]
  • (PMID = 19451225.001).
  • [ISSN] 1098-5549
  • [Journal-full-title] Molecular and cellular biology
  • [ISO-abbreviation] Mol. Cell. Biol.
  • [Language] ENG
  • [Grant] United States / NINDS NIH HHS / NS / P30 NS045776; United States / NINDS NIH HHS / NS / NS 045776; United States / NIMH NIH HHS / MH / R21 MH079213; United States / NIMH NIH HHS / MH / MH 079213; United States / NINDS NIH HHS / NS / P01 NS024279; United States / NCI NIH HHS / CA / R01 CA122617-04; United States / NINDS NIH HHS / NS / NS 024279; United States / NCI NIH HHS / CA / CA122617-04; United States / NCI NIH HHS / CA / R01 CA122617
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 0 / Multiprotein Complexes; 0 / Neurofibromin 2; 0 / Proteins; 0 / RNA, Small Interfering; 0 / Transcription Factors; 0 / mechanistic target of rapamycin complex 1; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.1 / TOR Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; W36ZG6FT64 / Sirolimus
  • [Other-IDs] NLM/ PMC2715803
  •  go-up   go-down


72. von Eckardstein KL, Driscoll CL, Link MJ: Outcome after microsurgery for meningiomas involving the internal auditory canal. Neurosurgery; 2010 Nov;67(5):1236-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcome after microsurgery for meningiomas involving the internal auditory canal.
  • BACKGROUND: The subset of patients suffering from meningiomas truly originating in or extending into the internal auditory canal is not well described in the literature.
  • OBJECTIVE: To evaluate postoperative facial motor and hearing outcomes in patients undergoing resection of meningiomas originating in or extending into the internal auditory canal.
  • METHODS: Chart reviews were done of 19 consecutive patients undergoing surgery for meningiomas originating in or extending into the internal auditory canal at the Mayo Clinic, Rochester, with emphasis on clinical exam and audiometry.
  • CONCLUSION: Every attempt should be made to preserve hearing and facial motor function in surgical removal of posterior fossa meningiomas that originate in or extend into the internal auditory canal.
  • [MeSH-major] Facial Paralysis / etiology. Hearing Loss / etiology. Meningeal Neoplasms / complications. Meningeal Neoplasms / surgery. Meningioma / complications. Meningioma / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20871449.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Bodi I, Hortobágyi T, Buk S: A 72-year-old woman with right frontal extra-axial mass. Brain Pathol; 2008 Apr;18(2):279-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of plasma cell predominant lymphoplasmacyte-rich meningioma with numerous crystalline inclusions.
  • Histology showed a benign meningioma with multifocal accumulation of numerous large cells with abundant eosinophilic cytoplasm, filled with lamellar inclusions and bipyramidal crystals.
  • Plasma cell inclusions have been reported occasionally in reactive inflammatory lesions but more frequently in plasma cell tumors and lymphoplasmacytic lymphoma, maybe associated with crystal-storing histiocytosis.
  • Although plasma cell predominant lymphoplasmacyte-rich meningioma is not uncommon, to our knowledge, similar crystalline inclusions in plasma cells have not been reported previously in meningioma.
  • [MeSH-major] Brain Neoplasms / pathology. Frontal Lobe / pathology. Meningeal Neoplasms / pathology. Meningioma / pathology

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18363938.001).
  • [ISSN] 1015-6305
  • [Journal-full-title] Brain pathology (Zurich, Switzerland)
  • [ISO-abbreviation] Brain Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Switzerland
  •  go-up   go-down


74. Prevedello DM, Thomas A, Gardner P, Snyderman CH, Carrau RL, Kassam AB: Endoscopic endonasal resection of a synchronous pituitary adenoma and a tuberculum sellae meningioma: technical case report. Neurosurgery; 2007 Apr;60(4 Suppl 2):E401; discussion E401
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endoscopic endonasal resection of a synchronous pituitary adenoma and a tuberculum sellae meningioma: technical case report.
  • OBJECTIVE: The presence of a sellar macroadenoma with a concomitant tuberculum sellae meningioma typically requires a craniotomy for extirpation of the meningioma.
  • INTERVENTION: After the endoscopic transnasal resection of the pituitary tumor, the planum sphenoidale was drilled and the underlying dura was incised.
  • The suprasellar tumor was identified and completely resected.
  • Histological evaluation confirmed the concomitant presence of a meningioma and pituitary adenoma.
  • CONCLUSION: With advances in endoscopic and image-guidance technology and increasing understanding of the endoscopic anatomy of the sellar region, surgeons are capable of reaching both intrasellar and suprasellar/anterior cranial base region tumors through a single endoscopic approach.
  • [MeSH-major] Adenoma / surgery. Endoscopy / methods. Meningioma / surgery. Neoplasms, Multiple Primary / surgery. Neurosurgical Procedures / methods. Pituitary Neoplasms / surgery. Sella Turcica / surgery
  • [MeSH-minor] Female. Headache / etiology. Humans. Magnetic Resonance Imaging. Middle Aged. Nasal Cavity / surgery. Neoplasm, Residual / diagnosis. Neoplasm, Residual / surgery. Postoperative Complications / etiology. Postoperative Complications / surgery. Recovery of Function. Reoperation. Vision Disorders / etiology


75. Smith JK: Parasellar tumors: suprasellar and cavernous sinuses. Top Magn Reson Imaging; 2005 Jul;16(4):307-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Parasellar tumors: suprasellar and cavernous sinuses.
  • This article will review the presentation and imaging appearance of tumors affecting the area around the pituitary gland.
  • For example, lesions affecting the suprasellar region include craniopharyngiomas, optic or hypothalamic gliomas, germ cell tumors, epidermoids, dermoids, hamartomas, lipomas, and choristomas.
  • Tumors that commonly affect the parasellar cavernous sinus include schwannomas and meningiomas.
  • Tumors like chordomas may arise in the sphenoid bone or clivus and affect the sella.
  • Metastasis, meningiomas and aneurysms may involve any area around the sella.
  • [MeSH-major] Cavernous Sinus / pathology. Sella Turcica / pathology. Skull Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16785846.001).
  • [ISSN] 0899-3459
  • [Journal-full-title] Topics in magnetic resonance imaging : TMRI
  • [ISO-abbreviation] Top Magn Reson Imaging
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 39
  •  go-up   go-down


76. Kimball MM, Friedman WA, Foote KD, Bova FJ, Chi YY: Linear accelerator radiosurgery for cavernous sinus meningiomas. Stereotact Funct Neurosurg; 2009;87(2):120-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Linear accelerator radiosurgery for cavernous sinus meningiomas.
  • OBJECTIVE: In this paper, the authors review the results of a single-center experience using linear accelerator (LINAC) radiosurgery for the treatment of cavernous sinus meningiomas.
  • Changes in preradiosurgery cranial nerve deficits and symptoms as well as actuarial local tumor control were evaluated.
  • RESULTS: The actuarial local tumor control was 100% at 5 years and 98% at 10 years.
  • One patient had enlargement of tumor.
  • CONCLUSIONS: This is the largest LINAC radiosurgery experience for cavernous sinus meningiomas reported to date.
  • Radiosurgery appears to offer greatly superior tumor control and much lower morbidity than surgical resection of cavernous sinus meningiomas.
  • [MeSH-major] Cavernous Sinus / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Radiosurgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2009 S. Karger AG, Basel.
  • (PMID = 19246961.001).
  • [ISSN] 1423-0372
  • [Journal-full-title] Stereotactic and functional neurosurgery
  • [ISO-abbreviation] Stereotact Funct Neurosurg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


77. Hamm K, Henzel M, Gross MW, Surber G, Kleinert G, Engenhart-Cabillic R: Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas. Zentralbl Neurochir; 2008 Feb;69(1):14-21
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiosurgery/stereotactic radiotherapy in the therapeutical concept for skull base meningiomas.
  • OBJECTIVE: Microsurgical resection is still the treatment of choice for skull base meningiomas.
  • But the risk of postoperative neurological deficits is high, and in many of these cases complete tumor removal cannot be achieved.
  • 129 of 224 had recurrences after 1 to 3 prior tumor resections and 95 of 224 were treated with SRT/RS alone.
  • 87.9% of cases had benign, 7.8% had atypical and 4.3% had malignant meningiomas.
  • Tumor volumes ranged from 0.16 ccm to 3.56 ccm.
  • The other 213 patients had larger tumor volumes of up to 135 ccm or a meningioma close to optical structures.
  • Follow-up data were available in 181 skull base meningiomas and the progression-free and overall survival rates, the toxicity and symptomatology were evaluated.
  • Two tumor progressions have occurred to date but further follow up is required.
  • Tumor volumes (TV) had shrunk about by 19.7% at 6 months (p<0.0001) and by 23.2% at 12 months (p<0.01) after SRT/RS.
  • CONCLUSION: SRT and RS offer an additional or alternative treatment option with a high efficacy and few side effects for the tumor control of skull base meningiomas.
  • In cases of large TV (>4 ccm), tumors adjacent to critical structures (<2 mm) or in high-risk patients the use of SRT offers greater benefits.
  • [MeSH-major] Meningioma / surgery. Neurosurgical Procedures. Radiosurgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Disease-Free Survival. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Middle Aged. Quality of Life. Survival Analysis. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18393160.001).
  • [ISSN] 0044-4251
  • [Journal-full-title] Zentralblatt für Neurochirurgie
  • [ISO-abbreviation] Zentralbl. Neurochir.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


78. Sulkin TV, Cousens C: SPECTCT cerebral perfusion scintigraphy; is the low-dose CT component of diagnostic value? Clin Radiol; 2008 Mar;63(3):289-98
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A single abnormality was demonstrated on 48 (23%), and two abnormalities on four (2%) of the remaining 211 studies.
  • Other findings included a chronic subdural haematoma, a meningioma, and a posterior fossa cyst.
  • [MeSH-major] Brain / radiography. Brain Diseases / radiography. Tomography, Emission-Computed, Single-Photon / methods. Tomography, X-Ray Computed / methods

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18275869.001).
  • [ISSN] 0009-9260
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Oximes; 0 / hexamethylpropyleneamine oxime
  •  go-up   go-down


79. Martorano P, Facco E, Falzetti G, Pelaia P: Spectral entropy assessment with auditory evoked potential in neuroanesthesia. Clin Neurophysiol; 2007 Mar;118(3):505-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twenty patients submitted to elective supratentorial neurosurgery for removal of a temporal-parietal meningioma were included in the study.
  • [MeSH-minor] Adolescent. Adult. Aged. Conscious Sedation / methods. Consciousness / physiology. Female. Humans. Male. Meningeal Neoplasms / surgery. Meningioma / surgery. Middle Aged. Neurosurgical Procedures. Prospective Studies. Sensitivity and Specificity. Wakefulness / physiology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17185033.001).
  • [ISSN] 1388-2457
  • [Journal-full-title] Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
  • [ISO-abbreviation] Clin Neurophysiol
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Netherlands
  •  go-up   go-down


80. Butte PV, Pikul BK, Hever A, Yong WH, Black KL, Marcu L: Diagnosis of meningioma by time-resolved fluorescence spectroscopy. J Biomed Opt; 2005 Nov-Dec;10(6):064026
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diagnosis of meningioma by time-resolved fluorescence spectroscopy.
  • We investigate the use of time-resolved laser-induced fluorescence spectroscopy (TR-LIFS) as an adjunctive tool for the intraoperative rapid evaluation of tumor specimens and delineation of tumor from surrounding normal tissue.
  • Experiments are conducted on excised specimens (meningioma, dura mater, cerebral cortex) from 26 patients (97 sites).
  • Our results reveal that meningioma is characterized by unique fluorescence characteristics that enable discrimination of tumor from normal tissue with high sensitivity (>89%) and specificity (100%).
  • Our findings establish the feasibility of using TR-LIFS as a tool for the identification of meningiomas and enables further development of real-time diagnostic tools for analyzing surgical tissue specimens of meningioma or other brain tumors.

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Biomed Opt. 2000 Apr;5(2):214-20 [10938786.001]
  • [Cites] N Engl J Med. 2001 Jan 11;344(2):114-23 [11150363.001]
  • [Cites] Photochem Photobiol. 2001 Apr;73(4):396-402 [11332035.001]
  • [Cites] Arterioscler Thromb Vasc Biol. 2001 Jul;21(7):1244-50 [11451759.001]
  • [Cites] Photochem Photobiol. 2003 Mar;77(3):309-18 [12685660.001]
  • [Cites] Lancet. 2004 May 8;363(9420):1535-43 [15135603.001]
  • [Cites] Appl Opt. 2004 May 10;43(14):2846-60 [15143808.001]
  • [Cites] J Biomed Opt. 2004 Jul-Aug;9(4):743-52 [15250761.001]
  • [Cites] Photochem Photobiol. 2004 Jul-Aug;80:98-103 [15339216.001]
  • [Cites] J Histochem Cytochem. 1979 Jan;27(1):36-43 [220325.001]
  • [Cites] Connect Tissue Res. 1989;19(1):77-92 [2791558.001]
  • [Cites] J Comput Assist Tomogr. 1990 Jul-Aug;14(4):497-504 [2164536.001]
  • [Cites] J Neurosurg. 1992 Apr;76(4):679-86 [1545262.001]
  • [Cites] Histol Histopathol. 1990 Jul;5(3):267-74 [2134380.001]
  • [Cites] Histopathology. 1993 Feb;22(2):113-25 [7681027.001]
  • [Cites] Ann Biomed Eng. 1993 Nov-Dec;21(6):573-89 [8116911.001]
  • [Cites] Annu Rev Phys Chem. 1996;47:555-606 [8930102.001]
  • [Cites] J Photochem Photobiol B. 1997 Jan;37(1-2):91-5 [9043097.001]
  • [Cites] J Korean Med Sci. 1997 Apr;12(2):135-42 [9170019.001]
  • [Cites] NMR Biomed. 1998 Jun-Aug;11(4-5):177-91 [9719572.001]
  • [Cites] Photochem Photobiol. 1998 Nov;68(5):603-32 [9825692.001]
  • [Cites] J Biol Chem. 1958 Dec;233(6):1455-67 [13610856.001]
  • (PMID = 16409091.001).
  • [ISSN] 1083-3668
  • [Journal-full-title] Journal of biomedical optics
  • [ISO-abbreviation] J Biomed Opt
  • [Language] ENG
  • [Grant] United States / NHLBI NIH HHS / HL / HL067377-01; United States / NHLBI NIH HHS / HL / R01 HL067377; United States / NHLBI NIH HHS / HL / R01 HL067377-01
  • [Publication-type] Evaluation Studies; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS245430; NLM/ PMC2981341
  •  go-up   go-down


81. Choi CY, Soltys SG, Gibbs IC, Harsh GR, Jackson PS, Lieberson RE, Chang SD, Adler JR: Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas. Neurosurgery; 2010 Nov;67(5):1180-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cyberknife stereotactic radiosurgery for treatment of atypical (WHO grade II) cranial meningiomas.
  • BACKGROUND: The optimal management of subtotally resected atypical meningiomas is unknown.
  • OBJECTIVE: To perform a retrospective review of patients with residual or recurrent atypical meningiomas treated with stereotactic radiosurgery (SRS).
  • SRS was delivered to with a median marginal dose of 22 Gy (range, 16-30) in 1 to 4 fractions (median, 1), targeting a median tumor volume of 5.3 cm³ (range, 0.3-26.0).
  • On univariate analysis, the number of recurrences before SRS (P = .046), late SRS (ie, waiting until tumor progression to initiate treatment) (P = .03), and age at treatment ≥ 60 years (P = .01) were significant predictors of recurrence.
  • CONCLUSION: Irradiation of the entire postoperative tumor bed may not be necessary for the majority of patients with subtotally resected atypical meningiomas.
  • [MeSH-major] Brain Neoplasms / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Radiosurgery / methods

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20871435.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


82. Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH: World Health Organization Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery; 2007 Dec;61(6):1194-8; discussion 1198
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] World Health Organization Grades II and III meningiomas are rare in the cranial base and spine.
  • OBJECTIVE: This study was undertaken to assess a possible relationship between the tumor location and the incidence of World Health Organization (WHO) Grades II and III meningiomas.
  • METHODS: A retrospective review of 794 consecutive patients who underwent meningioma resection between January 1991 and March 2004 was conducted.
  • Among these, 47 patients (5.9%) with WHO Grade II meningiomas and 16 patients (2%) with Grade III meningiomas were further analyzed.
  • Tumor location was assessed using preoperative magnetic resonance imaging scans and/or operative reports.
  • RESULTS: WHO Grade II tumors were found in eight out of 289 (2.8%) cranial base meningiomas and in zero spinal meningiomas, compared with 39 out of 429 (9.1%) non-cranial base meningiomas.
  • Grade III histology was encountered in two (0.7%) cranial base tumors and in one out of 76 (1.3%) spinal tumors, compared with 13 (3%) non-cranial base tumors.
  • The combined incidence of Grades II and III meningiomas was significantly lower in the cranial base (3.5%) and spinal (1.3%) locations compared with non-cranial base locations (12.1%) (P < 0.001).
  • CONCLUSION: WHO Grades II and III meningiomas occur far less frequently in the cranial base and spinal locations.
  • Tumors arising from these locations may have different mechanisms of tumorigenesis and/or progression compared with meningiomas arising from other (non-cranial base) regions.
  • [MeSH-major] Meningioma / diagnosis. Skull Base / pathology. Skull Base Neoplasms / diagnosis. Spinal Cord Neoplasms / diagnosis. Spine / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18162898.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


83. Plucińska I, Całka K, Jaźwiec P, Bojarski B, Czerniewicz-Kamińska A, Swiatkowska K, Sakowski J, Patrzyk R, Zwoliński J, Prudlak E: [Meningiomas of the anterior cranial fossa: clinical and radiological presentation--report of 2 cases]. Przegl Lek; 2007;64(9):601-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Meningiomas of the anterior cranial fossa: clinical and radiological presentation--report of 2 cases].
  • We reported two cases of the anterior cranial fossa meningiomas: cerebral falx meningioma and recurrence of olfactory groove meningioma.
  • Since the tumors grow very slowly, they remain clinically undetectable during the early stages and can reach a very large size.
  • Clinical manifestations are caused by pression of meningiomas on adjacent structures.
  • The authors present possibilities of radiological examinations of intracranial tumors and treatment management.
  • In the described cases meningiomas were diagnosed in CT examination with the use of angio option and reconstruction RT3D and MPR.
  • [MeSH-major] Meningioma / radiography. Meningioma / surgery. Skull Base Neoplasms / radiography. Skull Base Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18510084.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


84. Gupta SK, Mohindra S, Radotra BD, Khosla VK: Giant calvarial hyperostosis with biparasagittal en plaque meningioma. Neurol India; 2006 Jun;54(2):210-2
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant calvarial hyperostosis with biparasagittal en plaque meningioma.
  • We report a patient with an uncommon presentation in the form of massive bilateral calvarial hyperostosis with bi-parasagittal en plaque meningioma.
  • [MeSH-major] Hyperostosis / pathology. Meningioma / pathology. Skull Neoplasms / pathology

  • Genetic Alliance. consumer health - Calvarial Hyperostosis.
  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16804274.001).
  • [ISSN] 0028-3886
  • [Journal-full-title] Neurology India
  • [ISO-abbreviation] Neurol India
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


85. Cleary C, Curtin D: Giant atypical intraventricular meningioma presenting with visual loss in a child. Ir J Med Sci; 2010 Dec;179(4):617-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Giant atypical intraventricular meningioma presenting with visual loss in a child.
  • INTRODUCTION: Giant atypical intraventricular meningioma is very rare in childhood.
  • Atypical meningiomas are characterised by an increased mitotic ratio and MIB-1 expression, and demonstrate more aggressive tumour behaviour compared with typical meningiomas.
  • METHODS: We present the case of an 11-year-old girl who presented to the eye clinic complaining of reduced vision, and was diagnosed with a giant atypical intraventricular meningioma.
  • CONCLUSION: This case highlights the importance of ophthalmic examination in diagnosing brain tumours in children.
  • Such a large tumour located in the lateral ventricle may cause obstructive hydrocephalus, compression of brain tissue, seizures and loss of vision, and is potentially fatal.
  • [MeSH-major] Brain Neoplasms / diagnosis. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis. Vision Disorders / etiology


86. El Mahou S, Popa L, Constantin A, Jamard B, Cantagrel A, Mazieres B, Laroche M: Multiple intraosseous meningiomas. Clin Rheumatol; 2006 Jul;25(4):553-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple intraosseous meningiomas.
  • [MeSH-major] Meningeal Neoplasms / diagnostic imaging. Meningioma / diagnostic imaging. Neoplasms, Multiple Primary / diagnostic imaging. Skull Neoplasms / diagnostic imaging
  • [MeSH-minor] Diagnosis, Differential. Female. Fibrous Dysplasia of Bone / diagnosis. Humans. Middle Aged. Occipital Bone / diagnostic imaging. Occipital Bone / pathology. Osteoma / diagnosis. Temporal Bone / diagnostic imaging. Temporal Bone / pathology. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neurosurgery. 1988 May;22(5):882-5 [3380277.001]
  • [Cites] Acta Neurochir (Wien). 1990;107(1-2):56-60 [2096610.001]
  • [Cites] J Neurooncol. 1992 May;13(1):57-61 [1613538.001]
  • [Cites] Skeletal Radiol. 2000 Jun;29(6):354-7 [10929419.001]
  • [Cites] Neuroradiology. 1974;6(5):246-53 [4810615.001]
  • (PMID = 16273308.001).
  • [ISSN] 0770-3198
  • [Journal-full-title] Clinical rheumatology
  • [ISO-abbreviation] Clin. Rheumatol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


87. Munshi A, Dutta D, Muzumdar D, Jalali R: An atypical presentation of recurrent temporal lobe meningioma with external auditory canal mass. Indian J Cancer; 2007 Jul-Sep;44(3):119-21
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An atypical presentation of recurrent temporal lobe meningioma with external auditory canal mass.
  • Extracranial spread of recurrent meningiomas involving the middle ear is rare.
  • MRI revealed a lesion in the right temporal lobe suggestive of meningioma.
  • She was re-operated and histopathology was anaplastic meningioma.
  • [MeSH-major] Deafness / etiology. Ear Canal / pathology. Ear Neoplasms / secondary. Meningeal Neoplasms / pathology. Meningioma / pathology. Neoplasm Recurrence, Local / surgery. Temporal Lobe / pathology

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - Hearing Disorders and Deafness.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18250535.001).
  • [ISSN] 0019-509X
  • [Journal-full-title] Indian journal of cancer
  • [ISO-abbreviation] Indian J Cancer
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] India
  •  go-up   go-down


88. Arvold ND, Lessell S, Bussiere M, Beaudette K, Rizzo JF, Loeffler JS, Shih HA: Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys; 2009 Nov 15;75(4):1166-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma.
  • PURPOSE: Optic nerve sheath meningioma (ONSM) is a rare tumor that almost uniformly leads to visual dysfunction and even blindness without intervention.
  • CONCLUSIONS: Highly conformal, fractionated radiation therapy for symptomatic primary ONSM provides tumor control and improvement in visual function in most cases, with minimal treatment-induced morbidity.
  • Longer follow-up is needed to assess the durability of tumor control and treatment-related late effects.
  • [MeSH-major] Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy. Optic Nerve Neoplasms / radiotherapy. Radiotherapy, Conformal / methods. Visual Acuity

  • Genetic Alliance. consumer health - Meningioma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19406585.001).
  • [ISSN] 1879-355X
  • [Journal-full-title] International journal of radiation oncology, biology, physics
  • [ISO-abbreviation] Int. J. Radiat. Oncol. Biol. Phys.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Protons
  •  go-up   go-down


89. Mandelli C, Porras L, López-Sánchez C, Sicuri GM, Lomonaco I, García-Martínez V: The partial labyrinthectomy petrous apicectomy approach to petroclival meningiomas. A quantitative anatomic comparison with other approaches to the same region. Neurocirugia (Astur); 2008 Apr;19(2):133-42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The partial labyrinthectomy petrous apicectomy approach to petroclival meningiomas. A quantitative anatomic comparison with other approaches to the same region.
  • [MeSH-major] Ear, Inner / surgery. Meningeal Neoplasms / surgery. Meningioma / surgery. Otologic Surgical Procedures / methods. Petrous Bone / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18500412.001).
  • [ISSN] 1130-1473
  • [Journal-full-title] Neurocirugía (Asturias, Spain)
  • [ISO-abbreviation] Neurocirugia (Astur)
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Spain
  •  go-up   go-down


90. Umansky F, Shoshan Y, Rosenthal G, Fraifeld S, Spektor S: Radiation-induced meningioma. Neurosurg Focus; 2008;24(5):E7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiation-induced meningioma.
  • In the present article the authors review the literature relating to radiation-induced meningiomas (RIMs).
  • Emphasis is placed on meningiomas resulting from childhood treatment for primary brain tumor or tinea capitis, exposure to dental x-rays, and exposure to atomic explosions in Hiroshima and Nagasaki.
  • The authors review the typical presentation of patients with RIMs and discuss unique aspects of the surgical management of these tumors compared with sporadic meningioma, based on their clinical experience in treating these lesions.
  • [MeSH-major] Cranial Irradiation / adverse effects. Meningeal Neoplasms / etiology. Meningioma / etiology. Neoplasms, Radiation-Induced / etiology
  • [MeSH-minor] Adolescent. Adult. Alopecia / etiology. Brain Neoplasms / radiotherapy. Child. Cohort Studies. Dose-Response Relationship, Radiation. Female. Humans. Japan / epidemiology. Male. Neoplasm Invasiveness. Neoplasms, Second Primary / etiology. Neoplasms, Second Primary / radiotherapy. Neoplasms, Second Primary / surgery. Nuclear Warfare. Radiation Injuries / epidemiology. Radiation Injuries / etiology. Radiation Injuries / prevention & control. Radiography, Dental / adverse effects. Radiosurgery / adverse effects. Radiotherapy / trends. Tinea Capitis / radiotherapy


91. Aghi MK, Eskandar EN, Carter BS, Curry WT Jr, Barker FG 2nd: Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients. Clin Neurosurg; 2007;54:236-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Increased prevalence of obesity and obesity-related postoperative complications in male meningioma patients.
  • [MeSH-major] Meningeal Neoplasms / surgery. Meningioma / surgery. Obesity / complications. Obesity / epidemiology. Postoperative Complications / epidemiology
  • [MeSH-minor] Body Mass Index. Brain Neoplasms / epidemiology. Brain Neoplasms / surgery. Craniotomy. Cross-Sectional Studies. Fever / epidemiology. Fever / etiology. Glioma / epidemiology. Glioma / surgery. Humans. Intracranial Aneurysm / epidemiology. Intracranial Aneurysm / surgery. Length of Stay / statistics & numerical data. Male. Middle Aged. Patient Readmission / statistics & numerical data. Pulmonary Embolism / epidemiology. Pulmonary Embolism / etiology. Retrospective Studies. Risk Factors. Surgical Wound Infection / epidemiology. Surgical Wound Infection / etiology. Venous Thrombosis / epidemiology. Venous Thrombosis / etiology


92. Sonoda Y, Sakurada K, Saino M, Kondo R, Sato S, Kayama T: Multimodal strategy for managing meningiomas in the elderly. Acta Neurochir (Wien); 2005 Feb;147(2):131-6; discussion 136
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multimodal strategy for managing meningiomas in the elderly.
  • BACKGROUND: The incidence of brain tumors in elderly patients is increasing.
  • It has become possible to treat meningiomas in the elderly by several modalities.
  • METHODS: We registered 35 patients with meningiomas.
  • Symptomatic meningiomas were treated surgically at the time of diagnosis (n=19).
  • Of the 16 asymptomatic meningiomas, 5 were removed at the time of diagnosis.
  • The other asymptomatic meningiomas (n=11) were treated conservatively and when the tumors increased in size, surgical treatment was considered.
  • "Operated" patients with residual or recurrent tumors underwent radiosurgery with a gamma knife.
  • In all but two of the 11 patients with asymptomatic, conservatively treated meningiomas, the tumors did not increase during the follow-up period.
  • Gamma knife radiosurgery, performed to treat 3 residual and 1 recurrent tumor, resulted in very good tumor control and none of the tumors increased after gamma knife surgery.
  • CONCLUSIONS: Meningiomas in elderly patients require a multimodal approach.
  • Our strategy, which includes surgery, radiosurgery, and conservative treatment, resulted in good tumor control and made it possible for patients to pursue their activities of daily life.
  • [MeSH-major] Decision Trees. Meningeal Neoplasms / radiotherapy. Meningeal Neoplasms / surgery. Meningioma / radiotherapy. Meningioma / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15570440.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


93. Tahta K, Cirak B, Pakdemirli E, Suzer T, Tahta F: Postoperative mutism after removal of an anterior falcine meningioma. J Clin Neurosci; 2007 Aug;14(8):793-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Postoperative mutism after removal of an anterior falcine meningioma.
  • We present a 65-year-old man who had transient mutism after resection of anterior falx meningioma.
  • Histopathological examination revealed a mixed meningioma.
  • [MeSH-minor] Aged. Humans. Magnetic Resonance Imaging / methods. Male. Meningeal Neoplasms / surgery. Meningioma / surgery. Review Literature as Topic. Supratentorial Neoplasms / surgery. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Meningioma.
  • MedlinePlus Health Information. consumer health - After Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17493821.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


94. Núñez M, Perdomo S, Moreta J, Santos-Briz Á, González-Sarmiento R: The G1359A-CNR1 gene polymorphism is associated to glioma in Spanish patients. Clin Transl Oncol; 2010 Dec;12(12):825-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • MATERIAL AND METHODS: We have studied the G1359A polymorphism of the gene CNR1 with a TaqMan allelic discrimination assay in 200 patients diagnosed with glioma, 109 patients diagnosed with meningioma and 403 healthy subjects.
  • [MeSH-minor] Adult. Alleles. Female. Gene Frequency. Genetic Association Studies. Genetic Predisposition to Disease. Genotype. Humans. Male. Meningeal Neoplasms / genetics. Meningioma / genetics. Middle Aged. Spain

  • Genetic Alliance. consumer health - Glioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Med Genet. 2001 Dec 8;105(8):749-52 [11803524.001]
  • [Cites] Am J Pathol. 2007 May;170(5):1445-53 [17456751.001]
  • [Cites] J Mol Med (Berl). 2001;78(11):613-25 [11269508.001]
  • [Cites] Neurosci Lett. 2009 Sep 18;461(2):116-20 [19539700.001]
  • [Cites] J Neurosci. 1991 Feb;11(2):563-83 [1992016.001]
  • [Cites] Nat Med. 2000 Mar;6(3):313-9 [10700234.001]
  • [Cites] Pharmacol Ther. 2001 Apr;90(1):45-60 [11448725.001]
  • [Cites] Neuroscience. 2005;134(2):567-74 [15975726.001]
  • [Cites] Genes Dev. 2001 Jun 1;15(11):1311-33 [11390353.001]
  • [Cites] Cancer Res. 2001 Aug 1;61(15):5784-9 [11479216.001]
  • [Cites] Arch Gen Psychiatry. 2008 Jul;65(7):816-24 [18606954.001]
  • [Cites] Mol Cell Probes. 1999 Aug;13(4):321-3 [10441206.001]
  • [Cites] Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):97-103 [15108190.001]
  • [Cites] Nat Rev Cancer. 2002 Aug;2(8):616-26 [12154354.001]
  • [Cites] Annu Rev Pathol. 2006;1:97-117 [18039109.001]
  • [Cites] Neurosurg Rev. 2003 Jul;26(3):145-58 [12783270.001]
  • [Cites] Eur Neuropsychopharmacol. 2008 Jan;18(1):34-40 [17669634.001]
  • [Cites] Cancer. 2000 Jun 15;88(12):2887 [10870076.001]
  • [Cites] Drug Alcohol Depend. 2002 Feb 1;65(3):221-4 [11841893.001]
  • [Cites] Hum Mol Genet. 2005 Nov 15;14(22):3389-96 [16204352.001]
  • [Cites] Neurol Sci. 2007 Dec;28(6):304-10 [18175076.001]
  • [Cites] J Pharmacol Exp Ther. 2004 Mar;308(3):838-45 [14617682.001]
  • [Cites] Neuroscience. 1997 Mar;77(2):299-318 [9472392.001]
  • [Cites] J Neurochem. 2006 Aug;98(3):886-93 [16893424.001]
  • [Cites] Neuropharmacology. 2004 Sep;47(3):315-23 [15275820.001]
  • [Cites] Nucleic Acids Res. 1990 Dec 11;18(23):7142 [2263478.001]
  • [Cites] J Clin Neurosci. 2003 Mar;10(2):252-4 [12637065.001]
  • [Cites] Lancet Neurol. 2006 Dec;5(12):1045-54 [17110285.001]
  • [Cites] Am J Epidemiol. 1999 Apr 15;149(8):689-92 [10206617.001]
  • [Cites] Pharmacol Rev. 2002 Jun;54(2):161-202 [12037135.001]
  • [Cites] J Neurochem. 2001 Jan;76(2):594-601 [11208922.001]
  • (PMID = 21156413.001).
  • [ISSN] 1699-3055
  • [Journal-full-title] Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
  • [ISO-abbreviation] Clin Transl Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / CNR1 protein, human; 0 / Receptor, Cannabinoid, CB1
  •  go-up   go-down


95. Roth J, Margalit NS, Kesler A, Korn A, Ram Z: Peri-operative brainstem infarct in a patient with antiphospholipid antibody (APLA) syndrome. Acta Neurochir (Wien); 2006 Oct;148(10):1111-4; discussion 1115
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We present a case of a peri-operative stroke in a patient undergoing resection of a foramen magnum meningioma.
  • [MeSH-major] Antiphospholipid Syndrome / complications. Brain Stem Infarctions / etiology. Foramen Magnum. Intraoperative Complications. Meningioma / surgery. Skull Neoplasms / surgery

  • Genetic Alliance. consumer health - Antiphospholipid Syndrome.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16944054.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


96. Plesec TP, Prayson RA: Frozen section discrepancy in the evaluation of central nervous system tumors. Arch Pathol Lab Med; 2007 Oct;131(10):1532-40
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Frozen section discrepancy in the evaluation of central nervous system tumors.
  • Frozen section also provides an accurate preliminary diagnosis; however, certain lesions are recognized to cause diagnostic challenges at FS.
  • OBJECTIVE: To identify cases in which there was a discrepancy between the FS diagnosis and final diagnosis in the case to heighten awareness of common diagnostic pitfalls in surgical neuropathology.
  • DESIGN: All CNS FS cases involving a tumor diagnosis at FS or permanent section (N = 2156) from September 1997 until June 2005 were retrospectively reviewed.
  • Twelve (21.1%) of 57 discrepancies involved errors in classification of spindle cell lesions, most commonly confusing schwannomas or meningiomas with other lesions.
  • Nine (15.8%) of 57 discrepancies involved errors in the diagnosis of CNS lymphoma.
  • Four (7.0%) of 57 discrepancies involved errors in the overgrading of tumors.
  • Approximately 80% of the discrepant cases were classified into 5 categories: spindle cell lesions, astrocytoma versus oligodendroglioma, differential diagnosis of CNS lymphoma, reactive versus neoplastic process, and tumor overgrading.
  • [MeSH-major] Central Nervous System Neoplasms / diagnosis. Diagnostic Errors / statistics & numerical data. Frozen Sections / methods. Pathology, Surgical / methods
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Biomarkers, Tumor / analysis. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Intraoperative Period. Male. Middle Aged. Reproducibility of Results. Retrospective Studies

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17922589.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


97. Hadidy AM, Nadi MM, Ahmad TM, Al-Hussaini MA, Al-Abaddi AA, Musharbash AF, Maani WS: Descriptive epidemiological analysis, MRI signals intensity and histopathological correlations of meningiomas. Neurosciences (Riyadh); 2010 Jan;15(1):11-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Descriptive epidemiological analysis, MRI signals intensity and histopathological correlations of meningiomas.
  • OBJECTIVES: To present our experience in operated meningioma cases regarding their prevalence, anatomical location, multiplicity, presenting signs and symptoms, and the possible correlation between MRI signal intensity and histological grades to set criteria for radio-pathological diagnosis.
  • METHODS: In this retrospective study, operated meningioma cases in the Department of Neurosurgery, Jordan University Hospital (JUH), Amman, Jordan between January 1997 and January 2007 were reviewed.
  • RESULTS: Meningioma was more common in females than males with a ratio of 2.2:1.
  • Para-sagittal meningiomas were the most common (23.3%).
  • Multiple intracranial meningiomas were found in 4.4% of the cases.
  • CONCLUSION: The prevalence of meningioma among genders and its anatomical location at JUH corresponds to the published medical literature worldwide.
  • [MeSH-major] Meningeal Neoplasms / epidemiology. Meningeal Neoplasms / pathology. Meningioma / epidemiology. Meningioma / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20677585.001).
  • [ISSN] 1319-6138
  • [Journal-full-title] Neurosciences (Riyadh, Saudi Arabia)
  • [ISO-abbreviation] Neurosciences (Riyadh)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Saudi Arabia
  •  go-up   go-down


98. Borin A, Okada DM, Cruz OL: Intracanalicular meningioma: diagnostic by immunohistochemistry. Braz J Otorhinolaryngol; 2008 Jan-Feb;74(1):158
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracanalicular meningioma: diagnostic by immunohistochemistry.
  • [MeSH-major] Ear Neoplasms / diagnosis. Meningeal Neoplasms / diagnosis. Meningioma / diagnosis

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Rev Bras Otorrinolaringol (Engl Ed). 2008 Mar-Apr;74(2):320
  • (PMID = 18392520.001).
  • [ISSN] 1808-8694
  • [Journal-full-title] Brazilian journal of otorhinolaryngology
  • [ISO-abbreviation] Braz J Otorhinolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Brazil
  •  go-up   go-down


99. Yako K, Morita A, Ueki K, Kirino T: Subfrontal schwannoma. Acta Neurochir (Wien); 2005 Jun;147(6):655-7; discussion 657-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Subfrontal schwannoma is a rare disease, which can be mis-diagnosed as an olfactory meningioma or a neuroblastoma, because of similar clinical symptoms and signs and neuroradiological features.
  • [MeSH-major] Brain Neoplasms / diagnosis. Frontal Lobe / pathology. Frontal Lobe / radiography. Neurilemmoma / diagnosis
  • [MeSH-minor] Adolescent. Diagnosis, Differential. Humans. Male. Neuroblastoma / diagnosis

  • Genetic Alliance. consumer health - Schwannoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15824881.001).
  • [ISSN] 0001-6268
  • [Journal-full-title] Acta neurochirurgica
  • [ISO-abbreviation] Acta Neurochir (Wien)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Austria
  •  go-up   go-down


100. Moster ML: Detection and treatment of optic nerve sheath meningioma. Curr Neurol Neurosci Rep; 2005 Sep;5(5):367-75
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Detection and treatment of optic nerve sheath meningioma.
  • Optic nerve sheath meningioma is an uncommon tumor of middle age.
  • With modern neuroimaging, these tumors are relatively easy to diagnose.
  • [MeSH-major] Meningioma / diagnosis. Meningioma / therapy. Optic Nerve Neoplasms / diagnosis. Optic Nerve Neoplasms / therapy
  • [MeSH-minor] Diagnosis, Differential. Female. Humans. Image Processing, Computer-Assisted. Magnetic Resonance Imaging. Male. Middle Aged. Optic Disk / pathology. Vision, Ocular / physiology

  • Genetic Alliance. consumer health - Meningioma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Neuroophthalmol. 1996 Dec;16(4):247-51 [8956159.001]
  • [Cites] Eye (Lond). 1987;1 ( Pt 5):597-602 [3446540.001]
  • [Cites] Ophthalmology. 1990 May;97(5):585-91 [2342803.001]
  • [Cites] Ophthalmology. 2004 May;111(5):997-1008 [15121380.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):537-43 [12738331.001]
  • [Cites] Ophthalmology. 1992 Apr;99(4):560-6 [1584575.001]
  • [Cites] Int J Cancer. 2000 Dec 20;90(6):343-50 [11180138.001]
  • [Cites] Neurosurg Clin N Am. 2000 Oct;11(4):597-604 [11082170.001]
  • [Cites] Curr Opin Ophthalmol. 2000 Oct;11(5):367-71 [11148705.001]
  • [Cites] Clin Neuropathol. 2002 Jan-Feb;21(1):5-8 [11846045.001]
  • [Cites] J Clin Neuroophthalmol. 1981 Jun;1(2):101-17 [6213649.001]
  • [Cites] Arch Ophthalmol. 1985 Mar;103(3):383-5 [3977712.001]
  • [Cites] Am J Ophthalmol. 1988 Oct 15;106(4):450-7 [3177564.001]
  • [Cites] J Neurosurg. 1998 Jan;88(1):43-50 [9420071.001]
  • [Cites] Singapore Med J. 2004 Apr;45(4):166-9 [15094985.001]
  • [Cites] Acta Neurochir Suppl. 1996;65:95-8 [8738506.001]
  • [Cites] Surv Ophthalmol. 1981 Nov-Dec;26(3):109-27 [7336327.001]
  • [Cites] Am J Ophthalmol. 1978 Nov;86(5):704-9 [717529.001]
  • [Cites] Int Ophthalmol Clin. 2001 Winter;41(1):171-80 [11198144.001]
  • [Cites] Am J Ophthalmol. 2000 May;129(5):694-6 [10844079.001]
  • [Cites] Eye (Lond). 1996;10 ( Pt 6):744-6 [9091375.001]
  • [Cites] AJNR Am J Neuroradiol. 1992 Nov-Dec;13(6):1622-4 [1442440.001]
  • [Cites] Br J Ophthalmol. 2002 Nov;86(11):1265-8 [12386086.001]
  • [Cites] Neuroradiology. 1982;22(4):207-10 [7057994.001]
  • [Cites] AJNR Am J Neuroradiol. 2003 Jun-Jul;24(6):1167-70 [12812948.001]
  • [Cites] Arch Ophthalmol. 2002 Nov;120(11):1505-8 [12427064.001]
  • [Cites] Ophthalmology. 2002 May;109(5):890-9; discussion 899-900 [11986093.001]
  • [Cites] Bull Soc Belge Ophtalmol. 2000;275:73-8 [10853310.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1422-9 [12459365.001]
  • [Cites] Br J Ophthalmol. 1989 Dec;73(12 ):960-6 [2611192.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1975 Mar;123(3):453-8 [1124827.001]
  • [Cites] Clin Exp Ophthalmol. 2005 Apr;33(2):137-41 [15807820.001]
  • [Cites] J Neurosurg. 1989 Jan;70(1):37-40 [2909685.001]
  • [Cites] Ophthalmology. 1984 Nov;91(11):1313-26 [6514296.001]
  • [Cites] Arch Neurol. 1980 Dec;37(12 ):781-3 [7447767.001]
  • [Cites] Neurosurgery. 2002 May;50(5):950-5; discussion 955-7 [11950397.001]
  • [Cites] Radiol Clin North Am. 1987 May;25(3):561-81 [3575689.001]
  • [Cites] Surv Ophthalmol. 1999 May-Jun;43(6):519-24 [10416794.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):37-58, ix [10026728.001]
  • [Cites] Semin Ophthalmol. 2004 Sep-Dec;19(3-4):130-40 [15590556.001]
  • [Cites] J Neurosurg. 2005 Jan;102(s_supplement):143-146 [28306473.001]
  • [Cites] Neurosurgery. 2002 Oct;51(4):890-902; discussion 903-4 [12234395.001]
  • [Cites] J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1348-50 [12933956.001]
  • [Cites] Surv Ophthalmol. 1992 Nov-Dec;37(3):167-83 [1475751.001]
  • [Cites] J Neuroophthalmol. 1998 Jun;18(2):117-20 [9621268.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):215-21 [8407394.001]
  • [Cites] Br J Ophthalmol. 2003 Feb;87(2):246-7 [12543765.001]
  • [Cites] Ophthalmology. 2003 Oct;110(10):2019-30 [14522782.001]
  • [Cites] Radiother Oncol. 2004 Aug;72(2):169-74 [15297135.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):755-63 [7960976.001]
  • [Cites] Jpn J Ophthalmol. 2005 Jan-Feb;49(1):49-55 [15692775.001]
  • [Cites] Ann Neurol. 1987 Feb;21(2):131-7 [3827221.001]
  • [Cites] Ophthalmology. 1999 Feb;106(2):311-8 [9951483.001]
  • [Cites] J Neurosurg. 2004 Dec;101(6):951-9 [15597756.001]
  • [Cites] Br J Ophthalmol. 1980 Aug;64(8):553-8 [7426572.001]
  • [Cites] J Clin Neuroophthalmol. 1981 Jun;1(2):85-99 [6213657.001]
  • [Cites] Ophthalmology. 2004 Mar;111(3):565-7 [15019337.001]
  • (PMID = 16131419.001).
  • [ISSN] 1528-4042
  • [Journal-full-title] Current neurology and neuroscience reports
  • [ISO-abbreviation] Curr Neurol Neurosci Rep
  • [Language] eng
  • [Publication-type] Case Reports; Comparative Study; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 60
  •  go-up   go-down






Advertisement